NEW (2012) MESH HEADINGS WITH SCOPE NOTES (UNIT RECORD FORMAT; 12/14/2011)

TOTAL 2012 NEW DESCRIPTORS = 454


MH  - Abnormal Karyotype
UI  - D059786
MN  - C23.550.210.24
MN  - G5.360.162.679.500
MN  - G5.365.590.175.24
MS  - A variation from the normal set of chromosomes characteristic of a species.
HN  - 2012; use CHROMOSOME ABERRATIONS 2002-2011
BX  - Karyotype, Abnormal

MH  - Accessory Nerve Injuries
UI  - D061227
MN  - C10.292.175.500
MN  - C10.292.262.350
MN  - C10.900.300.218.225
MN  - C26.260.237.243
MN  - C26.915.300.400.200
MS  - Traumatic injuries to the ACCESSORY NERVE. Damage to the nerve may produce weakness in head rotation and shoulder elevation.
HN  - 2012

MH  - Accountable Care Organizations
UI  - D060866
MN  - N5.300.380.500
MS  - Organizations of health care providers that agree to be accountable for the quality, cost, and overall care of Medicare beneficiaries who are enrolled in the traditional fee-for-service program who are assigned to it. Assigned means those beneficiaries for whom the professionals in the organization provide the bulk of primary care services. (www.cms.gov/OfficeofLegislation/Downloads/Accountable CareOrganization.pdf accessed 03/16/2011)
HN  - 2012
BX  - Accountable Care Organization

MH  - Acidobacteria
UI  - D061271
MN  - B3.26
MN  - B3.440.400.50
MS  - A physiologically diverse phylum of acidophilic, gram-negative bacteria found in a wide variety of habitats, but particularly abundant in soils and sediments.
HN  - 2012

MH  - Acinar Cells
UI  - D061354
MN  - A11.31
MS  - Cells lining the saclike dilatations known as acini of various glands or the lungs.
HN  - 2012

MH  - Acute Pain
UI  - D059787
MN  - C10.597.617.88
MN  - C23.888.646.115
MS  - Intensely discomforting, distressful, or agonizing sensation associated with trauma or disease, with well-defined location, character, and timing.
HN  - 2012
FX  - Chronic Pain

MH  - Administration, Metronomic
UI  - D059250
MN  - E2.319.283.199
MS  - Administration of low doses of a drug or a drug combination over prolonged periods of time usually at a regular interval.
AN  - coordinate with specific drug / admin
HN  - 2012
FX  - Drug Chronotherapy
FX  - Maintenance Chemotherapy

MH  - Administration, Ophthalmic
UI  - D060433
MN  - E2.319.267.120.805
MN  - E2.319.267.639
MS  - Application of pharmaceutically active agents on the tissues of the eye ball.
HN  - 2012
BX  - Ocular Administration
FX  - Injections, Intraocular

MH  - Adrenergic Neurons
UI  - D059331
MN  - A8.663.766
MN  - A11.671.761
MS  - Neurons whose primary neurotransmitter is EPINEPHRINE.
AN  - ADRENERGIC FIBERS is also available
HN  - 2012
BX  - Noradrenergic Neurons
FX  - Adrenergic Fibers

MH  - Agatoxins
UI  - D060848
MN  - D12.776.92.249
MN  - D20.888.65.870.324
MN  - D23.946.833.65.870.324
MS  - A class of polyamine and peptide toxins which are isolated from the venom of spiders such as Agelenopsis aperta.
HN  - 2012

MH  - Agenesis of Corpus Callosum
UI  - D061085
MN  - C10.500.34
MN  - C16.131.666.34
MN  - C23.300.08
MS  - Birth defect that results in a partial or complete absence of the CORPUS CALLOSUM. It may be isolated or a part of a syndrome (e.g., AICARDI'S SYNDROME; ACROCALLOSAL SYNDROME; ANDERMANN SYNDROME; and HOLOPROSENCEPHALY). Clinical manifestations include neuromotor skill impairment and INTELLECTUAL DISABILITY of variable severity.
HN  - 2012;  for Absence of Corpus Callosum use Acrocallosal Syndrome 2009-2011; for Agenesis of Corpus Callosum use Aicardi Syndrome 2011
BX  - Absence of Corpus Callosum
BX  - Corpus Callosum Agenesis

MH  - Agricultural Inoculants
UI  - D059827
MN  - B1.300.53
MN  - B3.54
MS  - Beneficial microorganisms (bacteria or fungi) encapsulated in carrier material and applied to the environment for remediation and enhancement of agricultural productivity.
HN  - 2012
BX  - Microbial Inoculants
FX  - Agriculture
FX  - Environmental Remediation
FX  - Growth Substances

MH  - Agrobacterium
UI  - D060054
MN  - B3.440.400.425.700.24
MN  - B3.660.50.730.24
MS  - A genus of gram negative, aerobic, rod-shaped bacteria found in soil, plants, and marine mud.
HN  - 2012, 1963-2003; use RHIZOBIUM 1963-2011

MH  - Airway Extubation
UI  - D060666
MN  - E2.41.249
MN  - E5.08
MS  - Removal of an endotracheal tube from the patient.
HN  - 2012

MH  - Aliivibrio
UI  - D059706
MN  - B3.440.450.900.50
MN  - B3.660.250.830.50
MS  - A genus of gram-negative, rod-shaped bacteria in the family VIBRIONACEAE. They are found in the marine environment often associated with animals.
AN  - infection = ALIIVIBRIO INFECTIONS
HN  - 2012

MH  - Aliivibrio Infections
UI  - D059707
MN  - C1.252.400.50
MS  - Infections with bacteria of the genus ALIIVIBRIO.
HN  - 2012

MH  - alpha-2-HS-Glycoprotein
UI  - D060749
MN  - D12.776.124.790.106.304.500
MN  - D12.776.157.125.283.500
MN  - D12.776.215.625.500
MN  - D12.776.377.715.85.304.500
MN  - D12.776.395.86
MS  - A fetuin subtype that is synthesized by HEPATOCYTES and secreted into the circulation. It plays a major role in preventing CALCIUM precipitation in the BLOOD.
HN  - 2012(1981)
BX  - alpha2 Heremans-Schmid Glycoprotein

MH  - Alternariosis
UI  - D060487
MN  - C1.703.513.124
MS  - Opportunistic fungal infection by a member of ALTERNARIA genus.
HN  - 2012
BX  - Cutaneous Alternariosis

MH  - Amish
UI  - D061365
MN  - M1.686.754.133
MS  - An ethnic group with shared religious beliefs. Originating in Switzerland in the late 1600s, and first migrating to the mid-Atlantic, they now live throughout Eastern and Mid-Western United States and elsewhere. Communities are usually close-knit and marriage is within the community.
HN  - 2012

MH  - Analgesics, Short-Acting
UI  - D059846
MN  - D27.505.696.663.850.14.580
MN  - D27.505.954.427.40.381
MS  - Pain-alleviating drugs characterized by rapid action time.
HN  - 2012

MH  - Anatomic Landmarks
UI  - D059925
MN  - A1.111
MS  - Reference points located by visual inspection, palpation, or computer assistance, that are useful in localizing structures on or within the human body.
HN  - 2012
FX  - Fiducial Markers

MH  - Angina, Stable
UI  - D060050
MN  - C14.280.647.187.362
MN  - C14.907.585.187.362
MN  - C23.888.646.215.500.575
MS  - Persistent and reproducible chest discomfort usually precipitated by a physical exertion that dissipates upon cessation of such an activity. The symptoms are manifestations of MYOCARDIAL ISCHEMIA.
HN  - 2012
BX  - Chronic Stable Angina

MH  - Anhedonia
UI  - D059445
MN  - C10.597.606.57
MN  - C23.888.592.604.39
MN  - F1.700.39
MS  - Inability to experience pleasure due to impairment or dysfunction of normal psychological and neurobiological mechanisms. It is a symptom of many PSYCHOTIC DISORDERS (e.g., DEPRESSIVE DISORDER, MAJOR; and SCHIZOPHRENIA).
HN  - 2012

MH  - Animal Shells
UI  - D060105
MN  - A13.79
MS  - The hard rigid covering of animals including MOLLUSCS; TURTLES; INSECTS; and crustaceans.
AN  - EGG SHELL is also available
HN  - 2012
FX  - Shellfish

MH  - Anterior Cruciate Ligament Reconstruction
UI  - D059549
MN  - E2.718.50
MN  - E4.555.85
MN  - E4.555.110.26
MN  - E4.680.51
MS  - Rebuilding of the ANTERIOR CRUCIATE LIGAMENT to restore functional stability of the knee. AUTOGRAFTING or ALLOGRAFTING of tissues is often used.
HN  - 2012

MH  - Anthropology, Medical
UI  - D060432
MN  - F4.96.879.201.500
MN  - I1.76.284
MS  - Field of social science that is concerned with differences between human groups as related to health status and beliefs.
AN  - IM as the discipline (education, history, etc) only; NIM with no qualifiers as a coordinate
HN  - 2012
BX  - Medical Anthropology

MH  - Anti-N-Methyl-D-Aspartate Receptor Encephalitis
UI  - D060426
MN  - C4.588.614.550.112
MN  - C4.730.856.112
MN  - C10.228.140.430.124
MN  - C10.574.781.249
MN  - C20.111.258.124
MS  - Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.
HN  - 2012

MH  - Antibodies, Monoclonal, Humanized
UI  - D061067
MN  - D12.776.124.486.485.114.224.60
MN  - D12.776.124.790.651.114.224.60
MN  - D12.776.377.715.548.114.224.200
MS  - Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.
HN  - 2012
BX  - Antibodies, Humanized

MH  - Antigens, CD151
UI  - D060185
MN  - D12.776.543.982.251
MN  - D23.50.301.264.35.251
MN  - D23.101.100.110.251
MS  - Tetraspanin proteins found associated with LAMININ-binding INTEGRINS. The CD151 antigens may play a role in the regulation of CELL MOTILITY.
HN  - 2012(1996)

MH  - Antigens, CD274
UI  - D060890
MN  - D12.776.467.150.300
MN  - D12.776.543.95.300
MN  - D23.50.301.264.35.276.300
MN  - D23.50.301.285.400
MN  - D23.101.100.110.276.300
MN  - D23.529.168.300
MS  - An inhibitory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 PROTEIN. CD274 antigen provides negative signals that control and inhibit T-cell responses and is found at higher than normal levels on tumor cells, suggesting its potential role in TUMOR IMMUNE EVASION.
HN  - 2012
BX  - Programmed Cell Death 1 Ligand 1 Protein

MH  - Antigens, CD53
UI  - D060265
MN  - D12.776.543.982.153
MN  - D23.50.301.264.35.153
MN  - D23.101.100.110.106
MS  - Tetraspanin proteins found at high levels in cells of the lymphoid-myeloid lineage. CD53 antigens may be involved regulating the differentiation of T-LYMPHOCYTES and the activation of B-LYMPHOCYTES.
HN  - 2012(1987)

MH  - Antigens, CD63
UI  - D060149
MN  - D12.776.395.550.550.249
MN  - D12.776.543.550.527.249
MN  - D12.776.543.982.163
MN  - D12.776.543.990.24
MN  - D23.50.301.264.35.163
MN  - D23.101.100.110.163
MS  - Ubiquitously-expressed tetraspanin proteins that are found in late ENDOSOMES and LYSOSOMES and have been implicated in intracellular transport of proteins.
AN  - note CD63 antigen may be referred to in the literature as "lysosomal-associated membrane protein 3" however they are separate and distinct proteins
HN  - 2012(1990)

MH  - Antigens, CD81
UI  - D060225
MN  - D12.776.543.982.181
MN  - D23.50.301.264.35.181
MN  - D23.101.100.110.181
MS  - Tetraspanin proteins that are involved in a variety of cellular functions including BASEMENT MEMBRANE assembly, and in the formation of a molecular complexes on the surface of LYMPHOCYTES.
HN  - 2012(1990)

MH  - Antigens, CD9
UI  - D060245
MN  - D12.776.395.550.18
MN  - D12.776.543.550.90
MN  - D12.776.543.982.109
MN  - D23.50.301.264.35.109
MN  - D23.101.100.110.110
MS  - A subtype of tetraspanin proteins that play a role in cell adhesion, cell motility, and tumor metastasis. CD9 antigens take part in the process of platelet activation and aggregation, the formation of paranodal junctions in neuronal tissue, and the fusion of sperm with egg.
HN  - 2012(1988)

MH  - Apomixis
UI  - D060832
MN  - G8.686.785.760.830.249
MN  - G15.744.74
MS  - Asexual reproduction resulting in the formation of viable seeds from FLOWERS without fertlization (i.e. use of POLLEN). Progeny plants produced from apomictic seeds are perfect clones of the parent.
HN  - 2012

MH  - Argonaute Proteins
UI  - D060565
MN  - D8.811.277.352.355.350.810.500
MN  - D8.811.277.352.700.350.810.500
MN  - D12.776.157.725.500.906.500
MN  - D12.776.664.962.500.906.500
MS  - A family of RNA-binding proteins that has specificity for MICRORNAS and SMALL INTERFERING RNA molecules. The proteins take part in RNA processing events as core components of RNA-induced silencing complex.
HN  - 2012

MH  - Arthropod Proteins
UI  - D060829
MN  - D12.776.92
MS  - Proteins synthesized by organisms belonging to the phylum ARTHROPODA. Included in this heading are proteins from the subdivisions ARACHNIDA; CRUSTACEA; and HORSESHOE CRABS. Note that a separate heading for INSECT PROTEINS is listed under this heading.
HN  - 2012

MH  - Artificial Lens Implant Migration
UI  - D060437
MN  - C11.510.174
MN  - C26.392.500.249
MS  - The shifting and or tilting of implanted artificial lens resulting in impaired vision.
HN  - 2012

MH  - Ascorbate Peroxidases
UI  - D060387
MN  - D8.811.682.732.165
MS  - Peroxidases that utilize ASCORBIC ACID as an electron donor to reduce HYDROGEN PEROXIDE to WATER. The reaction results in the production of monodehydroascorbic acid and DEHYDROASCORBIC ACID.
HN  - 2012(1980)

MH  - Asthma, Occupational
UI  - D059366
MN  - C8.127.108.495
MN  - C8.674.95.495
MN  - C20.543.480.680.95.495
MN  - C24.102
MS  - Asthma attacks caused, triggered, or exacerbated by OCCUPATIONAL EXPOSURE.
HN  - 2012

MH  - Asymmetric Cell Division
UI  - D060049
MN  - G4.299.134.220.109
MN  - G4.299.151.224
MN  - G4.299.233.750.500.249
MN  - G5.355.105.109
MN  - G7.700.320.249.410.750.500.500
MS  - Unequal cell division that results in daughter cells of different sizes.
HN  - 2012
BX  - Asymmetric Stem Cell Division

MH  - Atrophic Vaginitis
UI  - D059268
MN  - C13.351.500.894.906.316
MS  - Inflammation of the vagina due to thinning of the vaginal wall and decreased lubrication associated with reduced estrogen levels at MENOPAUSE.
HN  - 2012

MH  - Axenic Culture
UI  - D061245
MN  - E1.370.225.875.74
MN  - E5.200.875.74
MN  - E5.240.124
MS  - Culture of an isolated organism free from any other associating or comtaminating organisms.
HN  - 2012
FX  - Germ-Free Life

MH  - Axin Protein
UI  - D060466
MN  - D5.500.117.500
MN  - D12.776.476.81.500
MS  - A scaffolding protein that is a critical component of the axin signaling complex which binds to ADENOMATOUS POLYPOSIS COLI PROTEIN; GLYCOGEN SYNTHASE KINASE 3; and CASEIN KINASE I.
HN  - 2012(1997)
BX  - Axin Proteins

MH  - Axin Signaling Complex
UI  - D060465
MN  - D5.500.117
MN  - D12.776.476.81
MS  - A specific complex of WNT SIGNALING PATHWAY proteins that mediates the phosphorylation-dependent destruction of cytosolic BETA-CATENIN. The complex is disrupted by cell surface binding of WNT PROTEINS, which allows beta-catenin levels to rise to the point where they migrate to the CELL NUCLEUS and activate transcription.
HN  - 2012
BX  - Axin Signaling Complex Proteins

MH  - B-Lymphocytes, Regulatory
UI  - D060151
MN  - A11.63.438.450.300
MN  - A11.118.637.555.567.550.450.300
MN  - A11.118.637.555.567.562.450.300
MN  - A15.145.229.637.555.567.550.450.300
MN  - A15.145.229.637.555.567.562.450.300
MN  - A15.382.32.438.450.300
MN  - A15.382.490.555.567.562.450.300
MS  - B-cells that have a role in regulating the immune response including the production of CYTOKINES. This function is in addition to their traditional role in making antibodies.
HN  - 2012

MH  - B7 Antigens
UI  - D060887
MN  - D12.776.467.150
MN  - D12.776.543.95
MN  - D23.50.301.264.35.276
MN  - D23.50.301.285
MN  - D23.101.100.110.276
MN  - D23.529.168
MS  - A family of cell-surface proteins found on ANTIGEN-PRESENTING CELLS. B7 antigens are ligands for specific cell surface receptor subtypes found on T-CELLS. They play an immunomodulatory role by stimulating or inhibiting the T-CELL activation process.
HN  - 2012; for B7 ANTIGEN and ANTIGEN B7 use ANTIGENS, CD80 1994-2011

MH  - Balamuthia mandrillaris
UI  - D059611
MN  - B1.46.90
MS  - A species of free-living soil amoeba in the family Balamuthiidae, causing AMEBIASIS and a deadly form of ENCEPHALITIS in humans.
AN  - infection: coordinate IM with AMEBIASIS (IM) + ENCEPHALITIS (IM) if pertinent; coordinate with specific protozoan terms (ANTIGENS, PROTOZOAN, etc.) if pertinent
HN  - 2012

MH  - Batch Cell Culture Techniques
UI  - D061249
MN  - E5.240.249.124
MS  - Methods for cultivation of cells, usually on a large-scale, in a closed system for the purpose of producing cells or cellular products to harvest.
HN  - 2012
BX  - Batch Culture Techniques
FX  - Bioreactors

MH  - Bays
UI  - D061006
MN  - G1.311.625.80
MN  - N6.230.440.80
MS  - An area of water mostly surrounded by land, usually smaller than a gulf, and affording access to the sea.
HN  - 2012
BX  - Inlets

MH  - Biological Control Agents
UI  - D061046
MN  - D20.215.191
MN  - J1.40.226
MS  - Organisms used strategically for their positive or adverse effect on the physiology and/or reproductive health of other species.
HN  - 2012

MH  - Bioluminescence Resonance Energy Transfer Techniques
UI  - D060807
MN  - E5.196.712.516.99
MS  - Techniques for determining the proximity of molecules based on ENERGY TRANSFER between bioluminescent chromophores and acceptor fluorophores that have overlapping emission and absorption spectra.
HN  - 2012

MH  - Biosimilar Pharmaceuticals
UI  - D059451
MN  - D20.215.261
MS  - BIOLOGIC PRODUCTS that are imitations but not exact replicas of innovator products.
HN  - 2012

MH  - Biphasic Insulins
UI  - D061265
MN  - D6.472.699.587.200.200
MN  - D12.644.548.586.200.200
MN  - D26.310.249
MS  - An insulin preparation that is designed to provide immediate and long term glycemic control in a single dosage. Biphasic insulin typically contains a mixture of REGULAR INSULIN or SHORT-ACTING INSULIN combined with a LONG-ACTING INSULIN.
HN  - 2012
BX  - Biphasic Insulin

MH  - Bisphosphonate-Associated Osteonecrosis of the Jaw
UI  - D059266
MN  - C5.116.852.87
MN  - C5.500.86
MN  - C7.320.86
MN  - C23.550.717.732.183
MS  - Necrotic jaws or other maxillofacial skeleton necrosis associated with bisphosphonate use (see BISPHOSPHONATES). Injury, dental procedures, and trauma can trigger the necrotic process.
HN  - 2012
BX  - Bisphosphonate Osteonecrosis
BX  - Bisphosphonate-Associated Osteonecrosis

MH  - Bone Anteversion
UI  - D060750
MN  - C5.116.214.500
MN  - C23.300.970.249
MS  - Malalignment of a bone in which its head and neck is rotated excessively forward or inward.
HN  - 2012

MH  - Bone Retroversion
UI  - D060751
MN  - C5.116.214.750
MN  - C23.300.970.374
MS  - Attachment of a bone in which its head and neck is rotated excessively backward.
HN  - 2012

MH  - Brachydactyly
UI  - D059327
MN  - C5.660.585.262
MN  - C16.131.621.585.262
MS  - Congenital anomaly of abnormally short fingers or toes.
AN  - coordinate IM with FINGERS / abnorm (IM) or TOES / abnorm (IM)
HN  - 2012

MH  - Brassinosteroids
UI  - D060406
MN  - D4.808.247.808.756.71
MS  - Plant steroids ubiquitously distributed throughout the plant kingdom. They play essential roles in modulating growth and differentiation of cells at nanomolar to micromolar concentrations.
HN  - 2012

MH  - Breakthrough Pain
UI  - D059390
MN  - C10.597.617.178
MN  - C23.888.646.182
MN  - F2.830.816.131
MN  - G11.561.600.810.444.393
MS  - Acute pain that comes on rapidly despite the use of pain medication.
HN  - 2012

MH  - Breast Milk Expression
UI  - D061186
MN  - F1.145.407.199.500
MS  - The act of evacuating BREAST MILK by hand or with a pump.
AN  - coordinate with BOTTLE FEEDING if pertinent
HN  - 2012
FX  - Milk Ejection

MH  - Calcifying Nanoparticles
UI  - D059587
MN  - D5.500.135
MN  - J1.637.512.600.150
MS  - Protein-mineral complexes that comprise substrates needed for the normal calcium-carbonate-phosphate homeostasis. Nanobacteria was the prior name for the particles which were originally thought to be microorganisms.
HN  - 2012

MH  - Calcium Ionophores
UI  - D061207
MN  - D27.505.519.562.374.100
MN  - D27.720.395.100
MS  - Chemical agents that increase the permeability of CELL MEMBRANES to CALCIUM ions.
HN  - 2012

MH  - Capillary Tubing
UI  - D060166
MN  - E7.123
MS  - Hollow cylindrical objects with an internal diameter that is small enough to fill by and hold liquids inside by CAPILLARY ACTION.
HN  - 2012

MH  - Cardio-Renal Syndrome
UI  - D059347
MN  - C12.777.419.780.400
MN  - C13.351.968.419.780.400
MN  - C14.280.434.156
MS  - Condition where a primary dysfunction of either heart or kidney results in failure of the other organ (e.g., HEART FAILURE with worsening RENAL INSUFFICIENCY).
HN  - 2012
BX  - Cardiorenal Syndrome

MH  - Cardiomegaly, Exercise-Induced
UI  - D059267
MN  - G9.330.190.281
MS  - Heart enlargement and other remodeling in cardiac morphology and electrical circutry found in individuals who participate in intense repeated exercises.
AN  - CARDIOMEGALY is also available
HN  - 2012

MH  - Carnivory
UI  - D060435
MN  - F1.145.113.547.400
MN  - F1.145.407.299
MS  - The consumption of animal flesh.
HN  - 2012

MH  - Carotid Intima-Media Thickness
UI  - D059168
MN  - E1.370.350.850.150
MN  - E1.370.370.180
MN  - G9.330.210
MS  - A measurement of the thickness of the carotid artery walls. It is measured by B-mode ULTRASONOGRAPHY and is used as a surrogate marker for ATHEROSCLEROSIS.
HN  - 2012
FX  - Tunica Intima
FX  - Tunica Media

MH  - Caves
UI  - D059552
MN  - G1.311.169
MN  - G16.500.275.67
MN  - N6.230.66
MS  - Geological formations consisting of underground enclosures with access from the surface.
HN  - 2012

MH  - Cell Cycle Checkpoints
UI  - D059447
MN  - G4.299.134.109
MS  - Regulatory signaling systems that control the progression through the CELL CYCLE. They ensure that the cell has completed, in the correct order and without mistakes, all the processes required to replicate the GENOME and CYTOPLASM, and divide them equally between two daughter cells. If cells sense they have not completed these processes or that the environment does not have the nutrients and growth hormones in place to proceed, then the cells are restrained (or "arrested") until the processes are completed and growth conditions are suitable.
AN  - general; prefer specifics
HN  - 2012
FX  - Cell Cycle Proteins
FX  - Genes, cdc

MH  - Cell Engineering
UI  - D060846
MN  - E5.240.311
MN  - J1.293.69.249
MS  - Methods and techniques used to modify or select cells and develop conditions for growing cells for biosynthetic production of molecules (METABOLIC ENGINEERING), for generation of tissue structures and organs in vitro (TISSUE ENGINEERING), or for other BIOENGINEERING research objectives.
HN  - 2012

MH  - Cellular Microenvironment
UI  - D060833
MN  - G4.366
MS  - Local surroundings with which cells interact by processing various chemical and physical signals, and by contributing their own effects to this environment.
HN  - 2012

MH  - Cementoplasty
UI  - D060826
MN  - E2.718.275
MN  - E4.555.165
MS  - Injection of BONE CEMENTS into bone to treat bone lesions.
HN  - 2012

MH  - Central Nervous System Sensitization
UI  - D059333
MN  - G11.561.148
MS  - An increased response to stimulation that is mediated by amplification of signaling in the CENTRAL NERVOUS SYSTEM (CNS).
HN  - 2012
BX  - Central Sensitization

MH  - Central Tolerance
UI  - D061167
MN  - G12.425.746.425.800.200
MS  - The mechanism, in central lymphoid organs (THYMUS; BONE MARROW), that prevents immature lymphocytes from reacting to SELF-ANTIGENS. This is accomplished by CLONAL ANERGY and CLONAL DELETION.
HN  - 2012

MH  - Cerebral Phaeohyphomycosis
UI  - D060425
MN  - C1.703.513.374
MS  - CNS infections caused by neurotropic dematiaceous fungi that contain melanin in their cell walls. The infections often result in BRAIN ABSCESS; ENCEPHALITIS; and MENINGITIS in patients who are often immunocompetent. The common causative fungi include members Cladophialophora bantiana, Exophiala dermatitidis, Rhinocladiella mackenziei, and Ochroconis gallopavum. R. mackenziei infection is seen almost exclusively in patients from the MIDDLE EAST.
HN  - 2012

MH  - Cerebral Small Vessel Diseases
UI  - D059345
MN  - C10.228.140.300.275
MN  - C14.907.253.329
MS  - Pathological processes or diseases where cerebral MICROVESSELS show abnormalities. They are often associated with aging, hypertension and risk factors for lacunar infarcts (see LACUNAR INFARCTION); LEUKOARAIOSIS; and CEREBRAL HEMORRHAGE.
HN  - 2012

MH  - Characidae
UI  - D060126
MN  - B1.50.150.900.493.130.150
MS  - A family of fresh water fish in the order CHARACIFORMES, which includes the Tetras.
HN  - 2012

MH  - Characiformes
UI  - D060125
MN  - B1.50.150.900.493.130
MS  - An order of fresh water fish with 18 families and over 1600 species. The order includes CHARACINS, hatchetfish, piranhas, and TETRAS.
HN  - 2012

MH  - Chemistry Techniques, Synthetic
UI  - D060326
MN  - E5.916.39
MN  - G2.607.750.155
MN  - J1.897.836.249
MS  - Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs.
HN  - 2012

MH  - Chemoradiotherapy
UI  - D059248
MN  - E2.186.79
MN  - E2.319.164
MN  - E2.815.160
MS  - Treatment that combines chemotherapy with radiotherapy.
AN  - coordinate with disease/ ther
HN  - 2012
BX  - Concurrent Chemoradiotherapy

MH  - Chemoradiotherapy, Adjuvant
UI  - D059186
MN  - E2.186.79.500
MN  - E2.319.164.500
MN  - E2.815.160.500
MS  - Combined chemotherapy and radiotherapy given to augment some other form of treatment such as surgery. It is commonly used in the therapy of cancer.
AN  - coordinate with disease/ ther
HN  - 2012
BX  - Adjuvant Chemoradiotherapy
FX  - Chemotherapy, Adjuvant
FX  - Radiotherapy, Adjuvant

MH  - Chilaiditi Syndrome
UI  - D059269
MN  - C6.405.469.158.93
MS  - Interposition of a portion of the colon (e.g., SIGMOID COLON) between the liver and teh diaphragm. It is associated with abdominal pain, vomiting, constipation, anorexia and volvulus. Chilaiditi anomoly refers to asymptomatic interposition.
HN  - 2012
BX  - Chilaiditi's Syndrome

MH  - Chlamydial Pneumonia
UI  - D061387
MN  - C1.252.400.210.210.124
MN  - C1.252.400.210.250.299
MN  - C1.252.620.249
MN  - C8.381.677.540.249
MN  - C8.730.610.540.249
MS  - Pneumonia caused by infections with the genus CHLAMYDiA; and CHLAMYDOPHILA, usually with CHLAMYDOPHILA PNEUMONIAE.
HN  - 2012; use PSITTACOSIS 2006-2011; use ORNITHOSIS 1963-2005

MH  - Chlorophyll Binding Proteins
UI  - D061146
MN  - D5.500.562.488.490.249
MN  - D8.811.600.710.490.249
MN  - D12.776.183.750.750.490.500
MN  - D12.776.543.983.500.490.249
MN  - D12.776.765.199.750.750.490.500
MS  - A large family of proteins that have been traditionally classified as the light-harvesting proteins of the photosynthetic reaction complex. Chlorophyll binding proteins are also found in non-photosynthetic settings where they may play a photoprotective role in response to light stress.
HN  - 2012; use LIGHT-HARVESTING PROTEIN COMPLEXES 2004-2011; for CHLOROPHYLL AB-PROTEINS, CHLOROPHYL A-PROTEINS, and CHLOROPHYLL AC-PROTEINS,  use LIGHT-HARVESTING PROTEIN COMPLEXES 2004-2011 and PHOTOSYNTHETIC REACTION CENTER COMPLEX PROTEINS 1991-2003

MH  - Chloroplast Proteins
UI  - D060365
MN  - D12.776.183
MN  - D12.776.765.199
MS  - Proteins encoded by the CHLOROPLAST GENOME or proteins encoded by the nuclear genome that are imported to and resident in the CHOROPLASTS.
HN  - 2012

MH  - Cholinergic Neurons
UI  - D059329
MN  - A8.663.127
MN  - A11.671.188
MS  - Neurons whose primary neurotransmitter is ACETYLCHOLINE.
AN  - CHOLINERGIC FIBERS is also available
HN  - 2012
FX  - Cholinergic Fibers

MH  - Chronic Pain
UI  - D059350
MN  - C10.597.617.258
MN  - C23.888.592.612.274
MS  - Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
AN  - differentiate from PAIN, INTRACTABLE
HN  - 2012
FX  - Acute Pain

MH  - Clonal Evolution
UI  - D060965
MN  - G4.299.350
MN  - G5.355.123
MS  - The process of accumulation of genetic and epigenetic changes over time in individual cells and the effect of the changes on CELL PROLIFERATION.
HN  - 2012
FX  - Clonal Selection, Antigen-Mediated

MH  - Clonal Selection, Antigen-Mediated
UI  - D060966
MN  - G12.425.199
MN  - G12.450.50.184
MS  - LYMPHOCYTE ACTIVATION by a specific ANTIGEN thus triggering clonal expansion of LYMPHOCYTES already capable of mounting an immune response to the antigen.
HN  - 2012
FX  - Antibody Formation
FX  - Clonal Evolution

MH  - Coal Ash
UI  - D060729
MN  - D20.633.110
MS  - Residue generated from combustion of coal or petroleum.
HN  - 2012

MH  - Coinfection
UI  - D060085
MN  - C1.539.218
MN  - C2.219
MS  - Simultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses.
AN  - coordinate with specific infections if pertinent
HN  - 2012
BX  - Mixed Infection

MH  - Consolidation Chemotherapy
UI  - D060830
MN  - E2.319.218
MS  - Drug treatment designed to further diminish the disease toward complete remission following INDUCTION CHEMOTHERAPY. It helps to consolidate the gains during induction chemotherapy and may be followed by MAINTENANCE CHEMOTHERAPY.
HN  - 2012

MH  - Construction Industry
UI  - D060389
MN  - J1.576.262
MS  - The aggregate business enterprise of building.
HN  - 2012
FX  - Construction Materials
FX  - Facility Design and Construction

MH  - Corneal Keratocytes
UI  - D060527
MN  - A11.329.228.109
MS  - Fibroblasts which occur in the CORNEAL STROMA.
HN  - 2012

MH  - Costimulatory and Inhibitory T-Cell Receptors
UI  - D061025
MN  - D12.776.543.750.705.222
MS  - A family of receptors that modulate the activation of T-LYMPHOCYTES by the T-CELL ANTIGEN RECEPTOR. The receptors are responsive to one or more B7 ANTIGENS found on ANTIGEN-PRESENTING CELLS and, depending upon the specific ligand-receptor combination, modulate a variety of T-cell functions such as the rate of clonal expansion, CELL SURVIVAL and cytokine production. Although commonly referred to as costimulatory receptors, some of the receptors have inhibitory effects such as inducing PERIPHERAL TOLERANCE.
HN  - 2012

MH  - Coxa Valga
UI  - D060906
MN  - C5.116.214.750.500
MN  - C5.116.327
MN  - C5.550.338
MN  - C23.300.970.374.500
MS  - Hip deformity in which the angle between the femoral neck and its shaft is increased. It may be congenital, acquired, or developmental.
HN  - 2012

MH  - Coxa Vara
UI  - D060905
MN  - C5.116.214.500.500
MN  - C5.550.353
MN  - C23.300.970.249.500
MS  - Hip deformity in which the femoral neck leans forward resulting in a decrease in the angle between femoral neck and its shaft. It may be congenital often syndromic, acquired, or developmental.
HN  - 2012
BX  - Congenital Coxa Vara
FX  - Slipped Capital Femoral Epiphyses

MH  - Cronobacter
UI  - D059126
MN  - B3.440.450.425.198
MN  - B3.660.250.150.98
MS  - A genus of gram-negative opportunistic foodborne pathogens.
HN  - 2012

MH  - Cryogels
UI  - D059985
MN  - D20.280.320.375.500
MN  - D26.255.165.320.375.187
MS  - Macroporous hydrogels that are produced at subzero temperatures. Cryogels have pores that are produced by growing ice crystals and have been developed with a tissue-like elasticity that is suitable for cell immunization experiments.
HN  - 2012(2003)

MH  - CTLA-4 Antigen
UI  - D060908
MN  - D12.776.543.750.705.222.750
MN  - D23.50.301.264.35.281
MN  - D23.50.301.264.894.158
MN  - D23.101.100.110.281
MN  - D23.101.100.894.158
MS  - An inhibitory T CELL receptor that is closely related to CD28 ANTIGEN. It has specificity for CD80 ANTIGEN and CD86 ANTIGEN and acts as a negative regulator of peripheral T cell function. CTLA-4 antigen is believed to play role in inducing PERIPHERAL TOLERANCE.
HN  - 2012(1991)
BX  - Cytotoxic T-Lymphocyte Antigen 4

MH  - Dental Implant-Abutment Design
UI  - D059605
MN  - E6.780.345.625.500
MN  - E6.912.145.750
MS  - The plan and delineation of DENTAL IMPLANT fitting with DENTAL ABUTMENT.
HN  - 2012
BX  - Dental Implant Platform Switching
BX  - Dental Implant-Abutment Connection
BX  - Dental Implant-Abutment Interface
BX  - Morse Taper Dental Implant-Abutment Connection
BX  - Morse Taper Dental Implant-Abutment Interface

MH  - Depressive Disorder, Treatment-Resistant
UI  - D061218
MN  - F3.600.300.387
MS  - Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
HN  - 2012

MH  - Diet, High-Fat
UI  - D059305
MN  - G7.610.240.267
MS  - Consumption of excessive DIETARY FATS.
HN  - 2012
BX  - Diet, High Fat

MH  - Diffuse Noxious Inhibitory Control
UI  - D059328
MN  - E2.190.262
MN  - E3.91.322
MS  - A physiological process by which the perception of pain at a local area of the body is inhibited by a second painful stimulus administered at a distal body site
HN  - 2012

MH  - Dirofilaria repens
UI  - D060348
MN  - B1.50.500.500.294.700.750.700.300.230.650
MS  - A filarial parasite primarily affecting dogs and cats, but causing an emerging zoonosis in humans involving subcutaneous lesions. It is transmitted by MOSQUITOES.
AN  - infection = DIROFILARIASIS
HN  - 2012

MH  - Disease Eradication
UI  - D060740
MN  - N6.850.275
MS  - Termination of all transmission of infection by global extermination of the infectious agent through surveillance and containment (From Porta, A Dictionary of Epidemiology, 5th ed).
AN  - coordinate with specific disease / prev
HN  - 2012
FX  - Communicable Disease Control

MH  - Disease Resistance
UI  - D060467
MN  - C23.550.291.671
MN  - G12.450.564.250
MN  - G12.450.800.250
MN  - G15.602.250
MS  - The capacity of an organism to defend itself against pathological processes or the agents of those processes. This most often involves innate immunity whereby the organism responds to pathogens in a generic way. The term disease resistance is used most frequently when referring to plants.
HN  - 2012; use IMMUNITY, INNATE 1978-2011

MH  - DNA End-Joining Repair
UI  - D059766
MN  - G2.111.87.219.200
MN  - G2.149.115.219.200
MN  - G5.355.195.200
MS  - The repair of DOUBLE-STRAND DNA BREAKS by rejoining the broken ends of DNA to each other directly.
HN  - 2012
BX  - Non-Homologous DNA End-Joining

MH  - DNA Transformation Competence
UI  - D061269
MN  - G5.232
MN  - G6.99.112.805.500
MS  - The ability of bacterial cells to take up exogenous DNA and be genetically transformed by it.
HN  - 2012

MH  - DNA, B-Form
UI  - D059371
MN  - D13.444.308.196
MN  - G2.111.570.790.486.142
MN  - G5.360.580.121
MS  - The most common form of DNA found in nature. It is a right-handed helix with 10 base pairs per turn, a pitch of 0.338 nm per base pair and a helical diameter of 1.9 nm.
HN  - 2012; for DNA, B-FORM use DNA 2004-2011

MH  - Dopaminergic Neurons
UI  - D059290
MN  - A8.663.278
MN  - A11.671.270
MS  - Neurons whose primary neurotransmitter is DOPAMINE.
HN  - 2012

MH  - Dried Blood Spot Testing
UI  - D059788
MN  - E1.370.225.124.100.232
MN  - E5.200.124.100.232
MS  - Techniques for using whole blood samples collected on filter paper for a variety of clinical laboratory tests.
HN  - 2012

MH  - Drinking Water
UI  - D060766
MN  - D1.455.900.300
MN  - D1.650.550.925.199
MN  - J2.200.418
MN  - N6.850.860.510.915.149
MS  - Water that is intended to be ingested.
HN  - 2012
FX  - Fresh Water

MH  - Duddingtonia
UI  - D059586
MN  - B1.300.381.299
MS  - A genus of ascomycetous mitosporic fungi in the family Orbiliaceae. It is used for the biological control of nematodes in livestock.
HN  - 2012

MH  - Dyscalculia
UI  - D060705
MN  - C10.597.606.150.550.99
MN  - C23.888.592.604.150.550.99
MN  - F3.550.350.500.99
MN  - F3.550.450.199
MS  - Impaired ability in numerical concepts. These inabilities arise as a result of primary neurological lesion, are syndromic (e.g., GERSTMANN SYNDROME ) or acquired due to brain damage.
HN  - 2012
FX  - Gerstmann Syndrome

MH  - Early Medical Intervention
UI  - D061345
MN  - N2.421.143.827.363
MS  - Action taken to reduce susceptibility or exposure to health problems and to detect and treat disease in early stages.
AN  - EARLY INTERVENTION (EDUCATION) is also available
HN  - 2012

MH  - Economics, Behavioral
UI  - D060909
MN  - F4.96.628.286
MN  - N3.219.215
MS  - The combined discipline of psychology and economics that investigates what happens in markets in which some of the agents display human limitations and complications.
AN  - use for the discipline (education, history, etc) only
HN  - 2012

MH  - Ecotype
UI  - D060146
MN  - G5.695.200
MN  - G16.500.275.157.49.230
MN  - N6.230.124.49.230
MS  - Geographic variety, population, or race, within a species, that is genetically adapted to a particular habitat. An ecotype typically exhibits phenotypic differences but is capable of interbreeding with other ecotypes.
HN  - 2012
FX  - Gene-Environment Interaction

MH  - Education of Hearing Disabled
UI  - D060345
MN  - I2.233.213.199
MS  - The teaching or training of those individuals with hearing disability or impairment.
HN  - 2012

MH  - Education of Visually Disabled
UI  - D060329
MN  - I2.233.213.500
MS  - The teaching or training of those individuals with visual disability.
HN  - 2012

MH  - Electromagnetic Radiation
UI  - D060733
MN  - G1.358.500.505
MN  - G1.750.250
MS  - Waves of oscillating electric and MAGNETIC FIELDS which move at right angles to each other and outward from the source.
HN  - 2012; for ELECTROMAGNETIC ENERGY and ELECTROMAGNETIC WAVES use RADIATION 1988-2011
BX  - Electromagnetic Energy
BX  - Electromagnetic Waves

MH  - Emergency Responders
UI  - D060731
MN  - M1.526.373
MS  - Personnel trained to provide the initial services, care, and support in EMERGENCIES or DISASTERS.
HN  - 2012

MH  - Emergency Shelter
UI  - D060447
MN  - N6.230.100.121
MS  - Temporary shelter provided in response to a major disaster or emergency.
HN  - 2012

MH  - Endocarditis, Non-Infective
UI  - D059905
MN  - C14.280.282.703
MS  - Formation of a non-infectious THROMBUS, referred to as vegetation, on previously undamaged ENDOCARDIUM. It usually occurs as a complication of connective-tissue diseases and cancers because of the associated hypercoagulable state (see THROMBOPHILIA).
HN  - 2012
BX  - Non-Bacterial Thrombotic Endocarditis

MH  - Endophytes
UI  - D060026
MN  - B5.237
MS  - An endosymbiont that is either a bacterium or fungus living part of its life in a plant. Endophytes can benefit host plants by preventing pathogenic organisms from colonizing them.
HN  - 2012
FX  - Symbiosis

MH  - Endoplasmic Reticulum Stress
UI  - D059865
MN  - G3.495.710.344
MN  - G4.299.486
MN  - G4.434
MS  - Various physiological or molecular disturbances that impair ENDOPLASMIC RETICULUM function. It triggers many responses, including UNFOLDED PROTEIN RESPONSE, which may lead to APOPTOSIS; and AUTOPHAGY.
HN  - 2012
BX  - Stress, Endoplasmic Reticulum
FX  - Unfolded Protein Response

MH  - Endoplasmic Reticulum-Associated Degradation
UI  - D060746
MN  - G2.111.87.675.871.790.600.962.500
MN  - G2.111.87.693.600.850.500
MN  - G2.149.115.675.871.790.600.850.500
MN  - G2.149.115.693.600.925.500
MN  - G3.495.770.871.790.600.850.500
MN  - G5.355.315.670.600.850.500
MS  - A degradation process whereby incorrectly folded proteins are selectively transported out of the ENDOPLASMIC RETICULUM and into the CYTOSOL. The misfolded proteins are subsequently ubiquitinated and degraded by the PROTEASOME.
HN  - 2012
FX  - Endoplasmic Reticulum Stress
FX  - Proteolysis
FX  - Ubiquitination

MH  - Energy Drinks
UI  - D061215
MN  - J2.200.512
MS  - Beverages consumed as stimulants and tonics. They usually contain a combination of CAFFEINE with other substances such as herbal supplements; VITAMINS; AMINO ACIDS; and sugar or sugar derivatives.
HN  - 2012

MH  - Entomoplasmatales
UI  - D060366
MN  - B3.440.860.300
MS  - An order of nonhelical (ENTOMOPLASMATACEAE) and helical (SPIROPLASMATACEAE) gram-negative bacteria in the class MOLLICUTES, that are regularly associated with arthropod or plant hosts.
HN  - 2012

MH  - Equol
UI  - D060754
MN  - D3.438.150.266.450.400.281
MS  - A non-steroidal ESTROGEN generated when soybean products are metabolized by certain bacteria in the intestines.
HN  - 2012

MH  - Exome
UI  - D059472
MN  - G5.360.340.11
MS  - That part of the genome that corresponds to the complete complement of EXONS of an organism or cell.
HN  - 2012
FX  - Exons
FX  - Transcriptome

MH  - Facilitated Tucking
UI  - D060867
MN  - N2.421.88.120.59
MS  - A method of soothing PREMATURE INFANTS during POSTNATAL CARE. It involves holding the infant's arms and legs in flexed positions close to the midline of the TORSO.
HN  - 2012

MH  - Feeder Cells
UI  - D061252
MN  - A11.251.538
MS  - Cells used in COCULTURE TECHNIQUES which support the growth of the other cells in the culture. Feeder cells provide auxillary substances including attachment substrates, nutrients, or other factors that are needed for growth in culture.
HN  - 2012

MH  - Fertility Preservation
UI  - D059247
MN  - E2.875.800.625
MN  - E4.936.537.562
MN  - E5.820.800.625
MS  - A method of providing future reproductive opportunities before a medical treatment with known risk of loss of fertility. Typically reproductive organs or tissues (e.g., sperm, egg, embryos and ovarian or testicular tissues) are cryopreserved for future use before the medical treatment (e.g., chemotherapy, radiation) begins.
HN  - 2012
FX  - Oocyte Retrieval
FX  - Organ Sparing Treatments
FX  - Sperm Retrieval

MH  - Fetal Globulins
UI  - D060747
MN  - D12.776.320.525
MN  - D12.776.377.228
MS  - Specialized proteins that are preferentially expressed during FETAL DEVELOPMENT.
HN  - 2012; use FETAL PROTEINS 1984-2011

MH  - Fetuin-B
UI  - D060752
MN  - D12.776.124.790.106.304.750
MN  - D12.776.157.125.283.750
MN  - D12.776.215.625.750
MN  - D12.776.377.715.85.304.750
MS  - A fetuin subtype that is closely-related to ALPHA-2-HS-GLYCOPROTEIN. Although fetuin-B binds calcium, it is a minor component of SERUM and therefore it may not play a primary role in preventing serum calcium phosphate precipitation.
HN  - 2012

MH  - Fetuins
UI  - D060748
MN  - D12.776.124.790.106.304
MN  - D12.776.157.125.283
MN  - D12.776.215.625
MN  - D12.776.377.715.85.304
MS  - A family of calcium-binding alpha-globulins that are synthesized in the LIVER and play an essential role in maintaining the solubility of CALCIUM in the BLOOD. In addition the fetuins contain aminoterminal cystatin domains and are classified as type 3 cystatins.
HN  - 2012; use ALPHA-FETOPROTEINS 1975-2011

MH  - Fibrobacteres
UI  - D061306
MN  - B3.335
MN  - B3.440.425.410.47
MS  - A phylum of gram-negative bacteria closely related to the BACTEROIDETES. Species have been found in the gastrointestinal tracts of animals, especially termites, though indications are that species are more broadly distributed in other environments.
HN  - 2012

MH  - Firefighters
UI  - D061388
MN  - M1.526.373.400
MS  - Professional or volunteer members of a fire department who are trained to suppress fire and respond to related emergency.
HN  - 2012

MH  - Florigen
UI  - D060405
MN  - D12.776.765.342
MS  - Molecule produced in plant leaves that acts like a hormone by inducing flowering in the shoot apical meristem of buds and growing tips.
HN  - 2012

MH  - Food Storage
UI  - D061353
MN  - J1.576.423.200.387
MS  - Keeping food for later consumption.
HN  - 2012
FX  - Food Packaging
FX  - Food Preservation
FX  - Food Supply

MH  - Foraminotomy
UI  - D059526
MN  - E4.525.305
MS  - Surgical enlargement of the intervertebral foramina to relieve NERVE ROOT COMPRESSION.
HN  - 2012

MH  - Forgiveness
UI  - D061347
MN  - F1.470.383
MN  - F1.829.401.166
MS  - Excusing or pardoning for an offense or release of anger or resentment.
HN  - 2012

MH  - Functional Neuroimaging
UI  - D059907
MN  - E1.370.350.578.875
MN  - E1.370.376.537.625
MN  - E5.629.875
MS  - Methods for visualing REGIONAL BLOOD FLOW, metabolic, electrical, or other physiological activities in the CENTRAL NERVOUS SYSTEM using various imaging modalities.
AN  - coordinate with specific imaging modality if appropriate
HN  - 2012

MH  - Fusariosis
UI  - D060585
MN  - C1.539.800.200.383.500
MN  - C1.703.295.328.500
MN  - C1.703.513.500
MN  - C17.800.838.208.416.500
MS  - OPPORTUNISTIC INFECTIONS with the soil fungus FUSARIUM. Typically the infection is limited to the nail plate (ONYCHOMYCOSIS). The infection can however become systemic especially in an IMMUNOCOMPROMISED HOST (e.g., NEUTROPENIA) and results in cutaneous and subcutaneous lesions, fever, KERATITIS, and pulmonary infections.
HN  - 2012

MH  - G1 Phase Cell Cycle Checkpoints
UI  - D059585
MN  - G4.299.134.109.249
MN  - G4.299.134.500.320.500
MS  - Regulatory signaling systems that control the progression of the CELL CYCLE through the G1 PHASE and allow transition to S PHASE when the cells are ready to undergo DNA REPLICATION. DNA DAMAGE, or the deficiencies in specific cellular components or nutrients may cause the cells to halt before progressing through G1 phase.
HN  - 2012

MH  - G2 Phase Cell Cycle Checkpoints
UI  - D059565
MN  - G4.299.134.109.500
MN  - G4.299.134.500.340.500
MS  - CELL CYCLE regulatory signaling systems that are triggered by DNA DAMAGE or lack of nutrients during G2 PHASE. When triggered they restrain cells transitioning from G2 phase to M PHASE.
HN  - 2012

MH  - GABAergic Neurons
UI  - D059330
MN  - A8.663.289
MN  - A11.671.285
MS  - Neurons whose primary neurotransmitter is GAMMA-AMINOBUTYRIC ACID.
HN  - 2012

MH  - Gas, Natural
UI  - D059206
MN  - D20.345.369
MN  - N6.230.132.258.369
MS  - A combustible, gaseous mixture of low-molecular weight PARAFFIN hydrocarbons, generated below the surface of the earth. It contains mostly METHANE and ETHANE with small amounts of PROPANE; BUTANES; and higher hydrocarbons, and sometimes NITROGEN; CARBON DIOXIDE; HYDROGEN SULFIDE; and HELIUM. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
HN  - 2012
FX  - Oil and Gas Fields

MH  - Gastropexy
UI  - D059485
MN  - E4.210.471
MS  - Surgical fixation of the stomach to the abdominal wall.
HN  - 2012

MH  - Gene-Environment Interaction
UI  - D059647
MN  - G5.695.337
MS  - The combined effects of genotypes and environmental factors together on phenotypic characteristics.
HN  - 2012
FX  - Ecotype
FX  - Genetic Fitness
FX  - Genetic Predisposition to Disease

MH  - Genes, Chloroplast
UI  - D061125
MN  - G5.360.340.24.340.225
MN  - G5.420.275.249
MS  - Those nucleic acid sequences that function as units of heredity which are located within the CHLOROPLAST DNA.
HN  - 2012
FX  - DNA, Chloroplast

MH  - Genes, Modifier
UI  - D060045
MN  - G5.360.340.24.340.370
MS  - GENES with ALLELES that affect the PHENOTYPE associated with a nonallelic gene.
HN  - 2012
FX  - Epistasis, Genetic
FX  - Genes, Regulator
FX  - Multifactorial Inheritance
FX  - Penetrance
FX  - Quantitative Trait Loci
FX  - Quantitative Trait, Heritable

MH  - Genome Size
UI  - D059646
MN  - G5.360.340.37
MS  - The amount of DNA (or RNA) in one copy of a genome.
HN  - 2012

MH  - Genotyping Techniques
UI  - D060005
MN  - E5.393.442
MS  - Methods used to determine individuals' specific ALLELES or SNPS (single nucleotide polymorphisms).
HN  - 2012
FX  - DNA Fingerprinting
FX  - Genetic Linkage
FX  - Genome-Wide Association Study
FX  - Genotype

MH  - Geothermal Energy
UI  - D059207
MN  - N6.230.132.644.186
MS  - Thermal energy contained in the earth. It can be used directly to supply heat or converted to mechanical or electrical energy.  (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
HN  - 2012

MH  - Germ Theory of Disease
UI  - D060755
MN  - K1.752.667.555
MS  - The fundamental tenet of modern medicine that certain diseases are caused by microorganisms. It was confirmed by the work of Pasteur, Lister, and Koch.
HN  - 2012

MH  - Gingival Retraction Techniques
UI  - D060745
MN  - E6.912.480
MS  - Techniques used to expose dental surface below the gingival margin in order to obtain better dental impression during periodental and peri-implant applications. The retraction of the gingival tissue can be achieved surgically (e.g., laser gingivectomy and rotary curettage) or chemically with a retraction cord.
HN  - 2012

MH  - Glenoid Cavity
UI  - D061165
MN  - A2.835.232.87.783.450
MS  - A depression in the lateral angle of the scapula that articulates with the head of the HUMERUS.
HN  - 2012

MH  - Glomerular Filtration Barrier
UI  - D060730
MN  - A5.810.453.324.359.372
MN  - A5.810.453.736.520.372
MN  - A7.500
MS  - A specialized barrier in the kidney, consisting of the fenestrated CAPILLARY ENDOTHELIUM; GLOMERULAR BASEMENT MEMBRANE; and glomerular epithelium (PODOCYTES). The barrier prevents the filtration of PLASMA PROTEINS.
HN  - 2012

MH  - Glossopharyngeal Nerve Injuries
UI  - D061287
MN  - C10.292.262.531
MN  - C10.292.450.500
MN  - C10.900.300.218.331
MN  - C26.260.237.365
MN  - C26.915.300.400.343
MS  - Traumatic injuries to the GLOSSOPHARYNGEAL NERVE.
HN  - 2012

MH  - Groundwater
UI  - D060587
MN  - G1.311.355
MN  - G16.500.275.325
MN  - N6.230.273
MS  - Liquid water present beneath the surface of the earth.
HN  - 2012
FX  - Water Supply

MH  - Gulf of Mexico
UI  - D060851
MN  - Z1.107.296
MS  - A body of water located at the southeastern corner of North America. It is bordered by the states to the north of Florida, Alabama, Mississippi, Louisiana, Texas; by five Mexican states to the west: Tamaulipas, Veracruz, Tabasco, Campeche, Yucatan; and by Cuba to the southeast.
HN  - 2012

MH  - Hand-Foot Syndrome
UI  - D060831
MN  - C17.800.174.600.587
MN  - C25.723.276.505.587
MS  - Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe ulcerative dermatitis with debilitating pain involving typically palmoplantar and intertriginous areas. These cutaneous manifestations are sometimes accompanied by nail anomalies.
AN  - do not confuse with HAND, FOOT AND MOUTH DISEASE
HN  - 2012
FX  - Hand, Foot and Mouth Disease

MH  - HapMap Project
UI  - D060148
MN  - H1.158.273.180.350.162
MN  - H1.158.273.343.249.199
MN  - H1.158.273.343.350.130
MN  - H1.770.644.145.350.249
MS  - A coordinated international effort to identify and catalog patterns of linked variations (HAPLOTYPES) found in the human genome across the entire human population.
AN  - CATALOG: use NAF entry
HN  - 2012
FX  - Haplotypes

MH  - Head Kidney
UI  - D060226
MN  - A13.449
MN  - A16.835.400
MS  - A primitive form of vertebrate kidney that is found in adults of some primitive FISHES and in the embryos of more advanced fishes. In some species of fishes it contains phagocytic cells and is also a major site of HEMATOPOIESIS, analogous to the mammalian BONE MARROW.
HN  - 2012
FX  - Hematopoiesis, Extramedullary

MH  - Heimlich Maneuver
UI  - D059746
MN  - E2.365.476
MS  - An emergency treatment commonly used to clear food and other foreign objects causing AIRWAY OBSTRUCTION.
HN  - 2012

MH  - Herbivory
UI  - D060434
MN  - F1.145.113.547.600
MN  - F1.145.407.758
MS  - The act of feeding on plants by animals.
HN  - 2012

MH  - Hereditary Breast and Ovarian Cancer Syndrome
UI  - D061325
MN  - C4.588.180.483
MN  - C4.588.322.455.431
MN  - C4.700.517
MN  - C13.351.500.56.630.705.431
MN  - C13.351.937.418.685.431
MN  - C16.320.700.517
MN  - C17.800.90.500.483
MN  - C19.344.410.431
MN  - C19.391.630.705.431
MS  - Autosomal dominant HEREDITARY CANCER SYNDROME in which a mutation most often in either BRCA1 or BRCA2 is associated with a significantly increased risk for breast and ovarian cancers.
AN  - coordinate IM with histological type of neoplasm (IM) if pertinent
HN  - 2012
FX  - BRCA1 Protein
FX  - BRCA2 Protein

MH  - Herniorrhaphy
UI  - D059685
MN  - E4.680.325
MS  - Surgical procedures undertaken to repair abnormal openings through which tissue or parts of organs can protrude or are already protruding.
HN  - 2012

MH  - Heterotaxy Syndrome
UI  - D059446
MN  - C14.240.400.592
MN  - C14.280.400.592
MN  - C15.604.744.146
MN  - C16.131.77.401
MN  - C16.131.240.400.592
MS  - Abnormal thoracoabdominal VISCERA arrangement (visceral heterotaxy) or malformation that involves additional CONGENITAL HEART DEFECTS (e.g., heart isomerism; DEXTROCARDIA) and/or abnormal SPLEEN (e.g., asplenia and polysplenia). Irregularities with the central nervous system, the skeleton and urinary tract are often associated with the syndrome.
HN  - 2012

MH  - HIV Serosorting
UI  - D059147
MN  - F1.145.699.400
MN  - F1.145.802.400
MS  - The practice of making choices about SEXUAL PARTNERS based on their HIV status.
HN  - 2012

MH  - HLA-A11 Antigen
UI  - D059870
MN  - D12.776.395.550.489.400.110
MN  - D12.776.543.550.421.400.110
MN  - D23.50.301.500.100.400.110
MN  - D23.50.301.500.450.370.110
MN  - D23.50.705.552.100.400.110
MN  - D23.50.705.552.450.370.500
MS  - A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*11 allele family.
HN  - 2012(1989)

MH  - HLA-A24 Antigen
UI  - D059871
MN  - D12.776.395.550.489.400.240
MN  - D12.776.543.550.421.400.240
MN  - D23.50.301.500.100.400.240
MN  - D23.50.301.500.450.370.240
MN  - D23.50.705.552.100.400.240
MN  - D23.50.705.552.450.370.600
MS  - A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*24 allele family.
HN  - 2012(1986)

MH  - HLA-B13 Antigen
UI  - D059908
MN  - D12.776.395.550.489.500.130
MN  - D12.776.543.550.421.500.130
MN  - D23.50.301.500.100.500.130
MN  - D23.50.301.500.450.380.130
MN  - D23.50.705.552.100.500.130
MN  - D23.50.705.552.450.380.130
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*13 allele family.
HN  - 2012(1983)

MH  - HLA-B14 Antigen
UI  - D059909
MN  - D12.776.395.550.489.500.140
MN  - D12.776.543.550.421.500.140
MN  - D23.50.301.500.100.500.140
MN  - D23.50.301.500.450.380.140
MN  - D23.50.705.552.100.500.140
MN  - D23.50.705.552.450.380.140
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*14 allele family.
HN  - 2012(1982)

MH  - HLA-B15 Antigen
UI  - D059910
MN  - D12.776.395.550.489.500.150
MN  - D12.776.543.550.421.500.150
MN  - D23.50.301.500.100.500.150
MN  - D23.50.301.500.450.380.150
MN  - D23.50.705.552.100.500.150
MN  - D23.50.705.552.450.380.150
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*15 allele family.
HN  - 2012(1981)
BX  - HLA B15 Antigen

MH  - HLA-B18 Antigen
UI  - D059911
MN  - D12.776.395.550.489.500.180
MN  - D12.776.543.550.421.500.180
MN  - D23.50.301.500.100.500.180
MN  - D23.50.301.500.450.380.180
MN  - D23.50.705.552.100.500.180
MN  - D23.50.705.552.450.380.180
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*18 allele family.
HN  - 2012(1981)

MH  - HLA-B37 Antigen
UI  - D059912
MN  - D12.776.395.550.489.500.370
MN  - D12.776.543.550.421.500.370
MN  - D23.50.301.500.100.500.370
MN  - D23.50.301.500.450.380.370
MN  - D23.50.705.552.100.500.370
MN  - D23.50.705.552.450.380.370
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*37 allele family.
HN  - 2012(1986)

MH  - HLA-B38 Antigen
UI  - D059945
MN  - D12.776.395.550.489.500.380
MN  - D12.776.543.550.421.500.380
MN  - D23.50.301.500.100.500.380
MN  - D23.50.301.500.450.380.380
MN  - D23.50.705.552.100.500.380
MN  - D23.50.705.552.450.380.380
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*38 allele family.
HN  - 2012(1987)
BX  - HLA B38 Antigen

MH  - HLA-B39 Antigen
UI  - D059946
MN  - D12.776.395.550.489.500.390
MN  - D12.776.543.550.421.500.390
MN  - D23.50.301.500.100.500.390
MN  - D23.50.301.500.450.380.390
MN  - D23.50.705.552.100.500.390
MN  - D23.50.705.552.450.380.390
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*39 allele family.
HN  - 2012(1987)

MH  - HLA-B40 Antigen
UI  - D059947
MN  - D12.776.395.550.489.500.400
MN  - D12.776.543.550.421.500.400
MN  - D23.50.301.500.100.500.400
MN  - D23.50.301.500.450.380.400
MN  - D23.50.705.552.100.500.400
MN  - D23.50.705.552.450.380.400
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*40 allele family.
HN  - 2012(1989)

MH  - HLA-B44 Antigen
UI  - D059948
MN  - D12.776.395.550.489.500.440
MN  - D12.776.543.550.421.500.440
MN  - D23.50.301.500.100.500.440
MN  - D23.50.301.500.450.380.440
MN  - D23.50.705.552.100.500.440
MN  - D23.50.705.552.450.380.440
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*44 allele family.
HN  - 2012(1985)

MH  - HLA-B51 Antigen
UI  - D059949
MN  - D12.776.395.550.489.500.510
MN  - D12.776.543.550.421.500.510
MN  - D23.50.301.500.100.500.510
MN  - D23.50.301.500.450.380.510
MN  - D23.50.705.552.100.500.510
MN  - D23.50.705.552.450.380.510
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*51 allele family.
HN  - 2012(1982)

MH  - HLA-B52 Antigen
UI  - D059950
MN  - D12.776.395.550.489.500.520
MN  - D12.776.543.550.421.500.520
MN  - D23.50.301.500.100.500.520
MN  - D23.50.301.500.450.380.520
MN  - D23.50.705.552.100.500.520
MN  - D23.50.705.552.450.380.520
MS  - A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*52 allele family.
HN  - 2012(1985)
BX  - HLA B52 Antigen

MH  - HLA-DP alpha-Chains
UI  - D059867
MN  - D12.776.395.550.509.400.420.500
MN  - D12.776.543.550.423.400.420.500
MN  - D23.50.301.500.400.400.420.500
MN  - D23.50.301.500.450.400.420.500
MN  - D23.50.705.552.410.400.420.500
MN  - D23.50.705.552.450.400.420.500
MS  - Transmembrane proteins that form the alpha subunits of the HLA-DP antigens.
HN  - 2012

MH  - HLA-DP beta-Chains
UI  - D059868
MN  - D12.776.395.550.509.400.420.750
MN  - D12.776.543.550.423.400.420.750
MN  - D23.50.301.500.400.400.420.750
MN  - D23.50.301.500.450.400.420.750
MN  - D23.50.705.552.410.400.420.750
MN  - D23.50.705.552.450.400.420.750
MS  - Transmembrane proteins that form the beta subunits of the HLA-DP antigens.
HN  - 2012

MH  - HLA-DQ alpha-Chains
UI  - D059848
MN  - D12.776.395.550.509.400.430.500
MN  - D12.776.543.550.423.400.430.500
MN  - D23.50.301.500.400.400.430.500
MN  - D23.50.301.500.450.400.430.500
MN  - D23.50.705.552.410.400.430.500
MN  - D23.50.705.552.450.400.430.500
MS  - Transmembrane proteins that form the alpha subunits of the HLA-DQ antigens.
HN  - 2012

MH  - HLA-DQ beta-Chains
UI  - D059866
MN  - D12.776.395.550.509.400.430.750
MN  - D12.776.543.550.423.400.430.750
MN  - D23.50.301.500.400.400.430.750
MN  - D23.50.301.500.450.400.430.750
MN  - D23.50.705.552.410.400.430.750
MN  - D23.50.705.552.450.400.430.750
MS  - Transmembrane proteins that form the beta subunits of the HLA-DQ antigens.
HN  - 2012

MH  - HLA-DR alpha-Chains
UI  - D059805
MN  - D12.776.395.550.509.400.440.100
MN  - D12.776.543.550.423.400.440.100
MN  - D23.50.301.500.400.400.440.100
MN  - D23.50.301.500.450.400.440.222
MN  - D23.50.705.552.410.400.440.100
MN  - D23.50.705.552.450.400.440.222
MS  - Transmembrane proteins that form the alpha subunits of the HLA-DR antigens. They are also referred to as the HLA-DR heavy chains.
HN  - 2012; for HLA-D ALPHA use HLA-DR ANTIGENS 1987-2011
BX  - HLA-DR alpha
BX  - HLA-DR alpha-Chain

MH  - HLA-DR beta-Chains
UI  - D059806
MN  - D12.776.395.550.509.400.440.200
MN  - D12.776.543.550.423.400.440.200
MN  - D23.50.301.500.400.400.440.200
MN  - D23.50.301.500.450.400.440.333
MN  - D23.50.705.552.410.400.440.200
MN  - D23.50.705.552.450.400.440.333
MS  - Transmembrane proteins that form the beta subunits of the HLA-DR antigens. They are also referred to as the HLA-DR light chains.
HN  - 2012; for HLA-D BETA use HLA-DR ANTIGENS 1987-2011
BX  - HLA-DR beta

MH  - HLA-DR Serological Subtypes
UI  - D059810
MN  - D12.776.395.550.509.400.440.400
MN  - D12.776.543.550.423.400.440.400
MN  - D23.50.301.500.400.400.440.400
MN  - D23.50.301.500.450.400.440.389
MN  - D23.50.705.552.410.400.440.389
MN  - D23.50.705.552.450.400.440.389
MS  - HLA-DR antigen subtypes that have been classified according to their affinity to specific ANTIBODIES. The DNA sequence analyses of HLA-DR ALPHA-CHAINS and HLA-DR BETA-CHAINS has for the most part revealed the specific alleles that are responsible for each serological subtype.
AN  - general; prefer specifics
HN  - 2012

MH  - HLA-DRB1 Chains
UI  - D059811
MN  - D12.776.395.550.509.400.440.200.10
MN  - D12.776.543.550.423.400.440.200.10
MN  - D23.50.301.500.400.400.440.200.10
MN  - D23.50.301.500.450.400.440.333.500
MN  - D23.50.705.552.410.400.440.200.10
MN  - D23.50.705.552.450.400.440.333.500
MS  - A subtype of HLA-DRB beta chains that includes over one hundred allele variants. The HLA-DRB1 subtype is associated with several of the HLA-DR SEROLOGICAL SUBTYPES.
HN  - 2012(1991)

MH  - HLA-DRB3 Chains
UI  - D059826
MN  - D12.776.395.550.509.400.440.200.30
MN  - D12.776.543.550.423.400.440.200.30
MN  - D23.50.301.500.400.400.440.200.30
MN  - D23.50.301.500.450.400.440.333.750
MN  - D23.50.705.552.410.400.440.200.30
MN  - D23.50.705.552.450.400.440.333.750
MS  - A subtype of HLA-DRB beta chains that includes over 50 allelic variants.  The HLA-DRB3 beta-chain subtype is associated with HLA-DR52 serological subtype.
HN  - 2012(1993)

MH  - HLA-DRB4 Chains
UI  - D059845
MN  - D12.776.395.550.509.400.440.200.40
MN  - D12.776.543.550.423.400.440.200.40
MN  - D23.50.301.500.400.400.440.200.40
MN  - D23.50.301.500.450.400.440.333.875
MN  - D23.50.705.552.410.400.440.200.40
MN  - D23.50.705.552.450.400.440.333.875
MS  - A subtype of HLA-DRB beta chains that is associated with the HLA-DR53 serological subtype.
HN  - 2012(1992)

MH  - HLA-DRB5 Chains
UI  - D059847
MN  - D12.776.395.550.509.400.440.200.50
MN  - D12.776.543.550.423.400.440.200.50
MN  - D23.50.301.500.400.400.440.200.50
MN  - D23.50.301.500.450.400.440.333.937
MN  - D23.50.705.552.410.400.440.200.50
MN  - D23.50.705.552.450.400.440.333.937
MS  - A subtype of HLA-DRB beta chains that is associated with the HLA-DR51 serological subtype.
HN  - 2012(1992)

MH  - HLA-G Antigens
UI  - D059951
MN  - D12.776.395.550.489.700
MN  - D12.776.543.550.421.700
MN  - D23.50.301.500.100.700
MN  - D23.50.301.500.450.700
MN  - D23.50.705.552.100.700
MN  - D23.50.705.552.450.700
MS  - Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.
HN  - 2012(1990)

MH  - Holy Roman Empire
UI  - D060786
MN  - Z1.586.361
MS  - Realm in central Europe consisting of a confederation of German and Italian territories under the suzerainty of an emperor and existing from the 9th or 10th century to 1806.
AN  - do not confuse with ROMAN EMPIRE see ROMAN WORLD or with ROME which is used for the ancient & modern city
HN  - 2012

MH  - Homologous Recombination
UI  - D059765
MN  - G5.355.760.615
MS  - An exchange of DNA between matching or similar sequences.
HN  - 2012

MH  - Hormesis
UI  - D059165
MN  - G7.700.370
MS  - Biphasic dose responses of cells or organisms (including microorganisms) to an exogenous or intrinsic factor, in which the factor induces stimulatory or beneficial effects at low doses and inhibitory or adverse effects at high doses.
HN  - 2012

MH  - Human Umbilical Vein Endothelial Cells
UI  - D061307
MN  - A11.436.275.682
MS  - Endothelial cells that line venous vessels of the UMBILICAL CORD.
HN  - 2012
FX  - Cells, Cultured

MH  - Hyalohyphomycosis
UI  - D060605
MN  - C1.539.800.200.383
MN  - C1.703.295.328
MN  - C1.703.513
MN  - C17.800.838.208.416
MS  - OPPORTUNISTIC INFECTIONS caused by a heterogeneous group of MITOSPORIC FUNGI with clear (hyalo-) HYPHAE in the host. Common causative agents include ACREMONIUM; ASPERGILLUS; CHRYSOSPORIUM; FUSARIUM; PAECILOMYCES; PENICILLIUM; PSEUDALLESCHERIA; SCEDOSPORIUM; and SCOPULARIOPSIS. Normally a dermatomycoses, it can become invasive in the IMMUNOCOMPROMISED HOST.
AN  - coordinate IM with specific fungus (IM) but note specifics
HN  - 2012

MH  - Hydrothermal Vents
UI  - D060086
MN  - G1.311.355.750.500.400
MN  - G16.500.275.325.500.400
MN  - N6.230.273.500.400
MS  - Hot springs on the ocean floor. They are commonly found near volcanically active places such as mid-oceanic ridges.
HN  - 2012

MH  - Hygiene Hypothesis
UI  - D061148
MN  - K1.752.667.875
MS  - The theory that infectious agents, symbiotic microorganisms, and parasites are normal stimulants for the maturation of the immune system toward a balanced immune response. The theory predicts that lack of such stimulation leads to allergies and AUTOIMMUNE DISEASES.
HN  - 2012
FX  - Therapy with Helminths

MH  - Hypoglossal Nerve Injuries
UI  - D061228
MN  - C10.292.262.562
MN  - C10.292.525.500
MN  - C10.900.300.218.362
MN  - C26.260.237.406
MN  - C26.915.300.400.387
MS  - Traumatic injuries to the HYPOGLOSSAL NERVE.
HN  - 2012

MH  - Imaginal Discs
UI  - D060227
MN  - A13.518
MS  - Hollow sacs of cells in LARVA that form adult structures in insects during BIOLOGICAL METAMORPHOSIS.
HN  - 2012
FX  - Larva

MH  - Immunochromatography
UI  - D059665
MN  - E5.196.181.400.170.500
MN  - E5.478.566.335
MS  - A type of affinity chromatography where ANTIBODIES are used in the affinity capture reaction on the solid support, in the mobile phase, or both.
HN  - 2012

MH  - In Vitro Oocyte Maturation Techniques
UI  - D059471
MN  - E2.875.800.906
MN  - E5.820.800.906
MS  - Methods used to induce premature oocytes, that are maintained in tissue culture, to progress through developmental stages including to a stage that is competent to undergo FERTILIZATION.
HN  - 2012
BX  - In Vitro Oocyte Maturation
FX  - Oocytes
FX  - Oogenesis

MH  - Index of Orthodontic Treatment Need
UI  - D061326
MN  - E5.318.308.250.300.512
MN  - E6.208.421
MN  - N5.715.360.300.375.300.505
MN  - N6.850.520.308.250.300.512
MN  - N6.890.160.134
MS  - A dental health survey developed to evaluate a patient's orthodontic treatment need and priority for orthodontic care. The index is based on an assessment of degree of MALOCCLUSION and the potential aesthetic and dental health benefit of the treatment under consideration.
HN  - 2012

MH  - Inducible T-Cell Co-Stimulator Ligand
UI  - D060945
MN  - D12.776.467.150.500
MN  - D12.776.543.95.500
MN  - D23.50.301.264.35.276.500
MN  - D23.50.301.285.500
MN  - D23.101.100.110.276.500
MN  - D23.529.168.500
MS  - A B7 antigen that binds specifically to INDUCIBLE T-CELL CO-STIMULATOR PROTEIN on T-CELLS. It provides a costimulatory signal for T-cell proliferation and cytokine secretion.
HN  - 2012(2000)

MH  - Inducible T-Cell Co-Stimulator Protein
UI  - D060889
MN  - D12.776.543.750.705.222.812
MN  - D23.50.301.264.35.285
MN  - D23.50.301.264.894.580
MN  - D23.101.100.110.285
MN  - D23.101.100.894.580
MS  - A costimulatory receptor that is specific for INDUCIBLE T-CELL CO-STIMULATOR LIGAND. The receptor is associated with a diverse array of immunologically-related effects including the increased synthesis of INTERLEUKIN 10 in REGULATORY T-LYMPHOCYTES and the induction of PERIPHERAL TOLERANCE.
HN  - 2012(1999)

MH  - Induction Chemotherapy
UI  - D060828
MN  - E2.319.499
MN  - E2.860.500
MS  - Initial drug treatment designed to bring about REMISSION INDUCTION. It is typically a short-term and high-dose drug treatment that is followed by CONSOLIDATION CHEMOTHERAPY and then MAINTENANCE CHEMOTHERAPY.
HN  - 2012

MH  - Infusions, Spinal
UI  - D060186
MN  - E2.319.267.510.794
MS  - The administration of medication by insertion of a tiny needle or catheter into the spinal sac or epidural cavity.
AN  - do not confuse with INJECTIONS, SPINAL
HN  - 2012

MH  - Insulin Aspart
UI  - D061267
MN  - D6.472.699.587.200.400.100
MN  - D12.644.548.586.200.400.100
MS  - Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.
HN  - 2012(1991)
BX  - Insulin-Aspart

MH  - Insulin Lispro
UI  - D061268
MN  - D6.472.699.587.200.400.500
MN  - D12.644.548.586.200.400.500
MS  - Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE.
HN  - 2012(1995)

MH  - Insulin, Lente
UI  - D061405
MN  - D6.472.699.587.200.300.300
MN  - D12.644.548.586.200.300.300
MS  - An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage.
HN  - 2012; use INSULIN, LONG-ACTING 1966-2011; for INSULIN, LENTE, MONOCOMPONENT use INSULIN, LONG-ACTING 1983-2011; for INSULIN, MONTARD and INSULIN NOVO MONOTARD use INSULIN, LONG-ACTING 1984-2011

MH  - Insulin, Regular, Human
UI  - D061386
MN  - D6.472.699.587.200.500.625.500
MN  - D12.644.548.586.200.500.625.500
MS  - Regular insulin preparations that contain the HUMAN insulin peptide sequence.
HN  - 2012; use INSULIN 2003-2011

MH  - Insulin, Regular, Pork
UI  - D061389
MN  - D6.472.699.587.200.500.625.700
MN  - D12.644.548.586.200.500.625.700
MS  - Regular insulin preparations that contain the SUS SCROFA insulin peptide sequence.
HN  - 2012; use INSULIN 2003-2011

MH  - Insulin, Short-Acting
UI  - D061266
MN  - D6.472.699.587.200.400
MN  - D12.644.548.586.200.400
MS  - Insulin derivatives and preparations that are designed to induce a rapid HYPOGLYCEMIC EFFECT.
HN  - 2012

MH  - Insulin, Ultralente
UI  - D061406
MN  - D6.472.699.587.200.300.800
MN  - D12.644.548.586.200.300.800
MS  - A preparation of insulin and zinc chloride in the form of a crystalline suspension. Typically the duration of ultralente insulin activity lasts between 18-30 hours after dosage.
HN  - 2012; use INSULIN, LONG-ACTING 1966-2011
BX  - Ultralente Insulin

MH  - Insulins
UI  - D061385
MN  - D6.472.699.587.200
MN  - D12.644.548.586.200
MS  - Peptide hormones that cause an increase in the absorption of GLUCOSE by cells within organs such as LIVER, MUSCLE and ADIPOSE TISSUE. During normal metabolism insulins are produced by the PANCREATIC BETA CELLS in response to increased GLUCOSE. Natural and chemically-modified forms of insulin are also used in the treatment of GLUCOSE METABOLISM DISORDERS such as DIABETES MELLITUS.
AN  - general or unspecified; prefer specifics
HN  - 2012

MH  - Interactive Ventilatory Support
UI  - D059725
MN  - E2.41.625.516
MN  - E2.880.820.516
MS  - Mechanical ventilation delivered to match the patient's efforts in breathing as detected by the interactive ventilation device.
HN  - 2012

MH  - Interferon-gamma Release Tests
UI  - D059425
MN  - E1.370.225.812.453
MN  - E5.200.812.453
MN  - E5.478.594.475
MN  - E5.478.707
MS  - The assay of INTERFERON-GAMMA released from lymphocytes after their exposure to a specific test antigen, to check for IMMUNOLOGIC MEMORY resulting from a previous exposure to the antigen. The amount of interferon-gamma released is usually assayed by an ENZYME-LINKED IMMUNOSORBENT ASSAY.
HN  - 2012
FX  - Interferon-gamma
FX  - Tuberculin Test
FX  - Tuberculosis

MH  - Intra-Abdominal Hypertension
UI  - D059325
MN  - C5.651.180.297
MN  - C14.907.303.297
MS  - Pathological elevation of intra-abdominal pressure (>12 mm Hg). It may develop as a result of SEPSIS; PANCREATITIS; capillary leaks, burns, or surgery. When the pressure is higher than 20 mm Hg, often with end-organ dysfunction, it is referred to as abdominal compartment syndrome.
HN  - 2012
BX  - Abdominal Compartment Syndrome

MH  - Intraabdominal Infections
UI  - D059413
MN  - C1.539.463
MS  - Infection within the PERITONEAL CAVITY. A frequent cause is an ANASTOMOTIC LEAK following surgery.
HN  - 2012

MH  - Kangaroo-Mother Care Method
UI  - D060127
MN  - E2.760.670.500
MN  - N2.421.88.120.140
MN  - N2.421.585.700.500
MS  - A method of continuously holding a partially wrapped baby to the chest, involving skin-to-skin contact. Originally it was a method of caring for LOW-BIRTH-WEIGHT INFANT in developing countries and is now more widespread in developed nations. Aside from encouraging breast feeding, the extra sleep that the infant gets assists in regulating body temperature, helps the baby conserve energy, and redirects calorie expenditures toward growth and weight gain.
AN  - humans only; check the tags HUMAN and INFANT or INFANT, NEWBORN
HN  - 2012; use INFANT CARE 2004-2011

MH  - Karyotype
UI  - D059785
MN  - G5.360.162.679
MS  - The full set of CHROMOSOMES presented as a systematized array of METAPHASE chromosomes from a photomicrograph of a single CELL NUCLEUS arranged in pairs in descending order of size and according to the position of the CENTROMERE. (From Stedman, 25th ed)
HN  - 2012
FX  - Karyotyping

MH  - Kasabach-Merritt Syndrome
UI  - D059885
MN  - C4.557.645.375.617
MN  - C15.378.140.855.645
MS  - Rapidly growing vascular lesion along the midline axis of the neck, upper trunk, and extremities that is characterized by CONSUMPTION COAGULOPATHY; THROMBOCYTOPENIA; and HEMOLYTIC ANEMIA. It is often associated with infantile Kaposiform HEMANGIOENDOTHELIOMA and other vascular tumors such as tufted ANGIOMA.
HN  - 2012
BX  - Hemangioma Thrombocytopenia Syndrome
BX  - Kasabach-Merritt Phenomenon
BX  - Thrombocytopenia-Hemangioma Syndrome

MH  - Kisspeptins
UI  - D059648
MN  - D12.644.276.836
MN  - D12.644.400.430
MN  - D12.776.624.776.546
MS  - Intercellular signaling peptides that were originally characterized by their ability to suppress NEOPLASM METASTASIS. Kisspeptins have since been found to play an important role in the neuroendocrine regulation of REPRODUCTION.
HN  - 2012

MH  - Laboratory Personnel
UI  - D059232
MN  - M1.526.502
MS  - Professionals, technicians, and assistants staffing LABORATORIES.
AN  - coordinate IM with type of lab or occup (IM)
HN  - 2012; use MEDICAL LABORATORY PERSONNEL 1992-2011
BX  - Laboratory Technicians

MH  - Lacazia
UI  - D060367
MN  - B1.300.381.502
MS  - A mitosporic ONYGENALES fungal genus. The species Lacazia loboi is the etiological agent of LOBOMYCOSIS in humans, dolphins, and other wild animals.
AN  - infection: coordinate IM with LOBOMYCOSIS (IM)
HN  - 2012
BX  - Lacazia loboi

MH  - Lakes
UI  - D060106
MN  - G1.311.580
MN  - G16.500.275.280.500
MN  - N6.230.232.500
MS  - Inland bodies of still or slowly moving FRESH WATER or salt water, larger than a pond, and supplied by RIVERS and streams.
HN  - 2012

MH  - Laryngeal Nerve Injuries
UI  - D061224
MN  - C8.360.424
MN  - C9.400.424
MN  - C10.292.262.937.750
MN  - C10.900.300.218.887.750
MN  - C26.260.237.912.750
MN  - C26.915.300.400.912.750
MS  - Traumatic injuries to the LARYNGEAL NERVE.
HN  - 2012

MH  - Laryngocele
UI  - D059608
MN  - C8.360.549
MN  - C8.695.520
MN  - C9.400.549
MN  - C16.131.740.650
MS  - Congenital anomalous dilitation of the laryngeal saccule that may extend internally into the airway or externally through the thyrohyoid membrane.
HN  - 2012

MH  - Laser Capture Microdissection
UI  - D061346
MN  - E1.370.225.998.221.580.500
MN  - E5.200.998.221.580.500
MN  - E5.591.560.500
MS  - Techniques using a laser to cut away and harvest a specific cell or cluster of cells from a tissue section while viewing it under the microscope.
HN  - 2012

MH  - LIM Domain Proteins
UI  - D060588
MN  - D12.776.512
MS  - A large class of structurally-related proteins that contain one or more LIM zinc finger domains. Many of the proteins in this class are involved in intracellular signaling processes and mediate their effects via LIM domain protein-protein interactions. The name LIM is derived from the first three proteins in which the motif was found: LIN-11, Isl1 and Mec-3.
HN  - 2012

MH  - LIM-Homeodomain Proteins
UI  - D060850
MN  - D12.776.260.529
MN  - D12.776.512.249
MS  - A subclass of LIM domain proteins that include an additional centrally-located homeodomain region that binds AT-rich sites on DNA. Many LIM-homeodomain proteins play a role as transcriptional regulators that direct cell fate.
HN  - 2012

MH  - Lingual Nerve Injuries
UI  - D061222
MN  - C10.292.262.875.500
MN  - C10.292.775.349.500
MN  - C10.900.300.218.775.500
MN  - C26.260.237.825.500
MN  - C26.915.300.400.825.500
MS  - Traumatic injuries to the LINGUAL NERVE. It may be a complication following dental treatments.
HN  - 2012

MH  - Liquid Phase Microextraction
UI  - D059627
MN  - E5.196.155.650.500
MS  - Miniaturized methods of liquid-liquid extraction.
HN  - 2012

MH  - Liquid-Liquid Extraction
UI  - D059625
MN  - E5.196.155.650
MS  - The removal of a soluble component from a liquid mixture by contact with a second liquid, immiscible with the carrier liquid, in which the component is preferentially soluble. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
HN  - 2012

MH  - Lobomycosis
UI  - D060368
MN  - C1.539.800.200.475
MN  - C1.703.295.475
MN  - C17.800.838.208.475
MS  - A chronic, fungal, subcutaneous infection endemic in rural regions in South America and Central America. The causal organism is Lacazia labol.
HN  - 2012

MH  - Lopinavir
UI  - D061466
MN  - D3.383.742.698.553
MS  - An antiretroviral drug of the protease inhibitor class used as a fixed-dose combination with RITONAVIR.
HN  - 2012

MH  - Low Density Lipoprotein Receptor-Related Protein-5
UI  - D060492
MN  - D12.776.526.500
MN  - D12.776.543.750.710.450.500.400
MN  - D12.776.543.750.962.687
MS  - LDL-receptor related protein that combines with FRIZZLED RECEPTORS at the cell surface to form receptors that bind WNT PROTEINS. The protein plays an important role in the WNT SIGNALING PATHWAY in OSTEOBLASTS and during EMBRYONIC DEVELOPMENT.
HN  - 2012(1998)

MH  - Low Density Lipoprotein Receptor-Related Protein-6
UI  - D060488
MN  - D12.776.526.600
MN  - D12.776.543.750.710.450.500.600
MN  - D12.776.543.750.962.781
MS  - An LDL-receptor related protein that combines with cell surface FRIZZLED RECEPTORS to form WNT PROTEIN-binding receptors. The protein plays an important role in the WNT SIGNALING PATHWAY during EMBRYONIC DEVELOPMENT and in regulation of vascular cell proliferation.
HN  - 2012(1999)

MH  - Lower Urinary Tract Symptoms
UI  - D059411
MN  - C23.888.942.343
MS  - Symptoms of disorders of the lower urinary tract including frequency, NOCTURIA; urgency, incomplete voiding, and URINARY INCONTINENCE. They are often associated with OVERACTIVE BLADDER; URINARY INCOMPETENCE; and INTERSTITIAL CYSTITIS. Lower urinary tract symptoms in males were traditionally called PROSTATISM.
HN  - 2012

MH  - Lymphoscintigraphy
UI  - D061305
MN  - E1.370.350.710.299
MN  - E1.370.384.730.176
MS  - Radionuclide imaging of the LYMPHATIC SYSTEM.
HN  - 2012

MH  - Lysosomal-Associated Membrane Protein 3
UI  - D059666
MN  - D12.776.395.550.550.875
MN  - D12.776.543.550.527.875
MN  - D23.50.301.264.35.533
MN  - D23.101.100.110.533
MS  - A lysosomal-associated membrane glycoprotein that is expressed at high levels in mature DENDRITIC CELLS.
AN  - note that LAMP-3 and Lysosomal-Associated Membrane Protein 3 appear in the literature as synonyms for CD63 antigen, however they are separate and distinct proteins
HN  - 2012; use LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS 2006-2011

MH  - M Phase Cell Cycle Checkpoints
UI  - D059566
MN  - G4.299.134.109.750
MN  - G4.299.134.220.220.781.337
MS  - The cellular signaling system that halts the progression of cells through MITOSIS or MEIOSIS if a defect that will effect CHROMOSOME SEGREGATION is detected.
HN  - 2012
BX  - M Phase Cell Cycle Checkpoint

MH  - Magnetic Fields
UI  - D060526
MN  - G1.358.750
MS  - Areas of attractive or repulsive force surrounding MAGNETS.
HN  - 2012

MH  - Magnetic Phenomena
UI  - D060328
MN  - G1.358
MS  - Characteristics, properties, and effects of magnetic substances and magnetic fields.
AN  - general or unspecified; prefer specifics
HN  - 2012
FX  - Magnetics
FX  - Magnetometry
FX  - Magnets

MH  - Magnetometry
UI  - D060306
MN  - E5.540
MS  - The measurement of various aspects of MAGNETIC FIELDS.
HN  - 2012

MH  - Magnets
UI  - D059346
MN  - J1.637.507
MS  - Objects that produce a magnetic field.
HN  - 2012
FX  - Magnetic Field Therapy
FX  - Magnetic Phenomena
FX  - Magnetics

MH  - Maintenance Chemotherapy
UI  - D060046
MN  - E2.319.509
MS  - Treatment designed to help prevent a relapse of a disease following the successful primary treatments (INDUCTION THERAPY and CONSOLIDATION THERAPY) with a long-term low-dose drug therapy.
HN  - 2012
FX  - Administration, Metronomic

MH  - Mallory Bodies
UI  - D059609
MN  - A11.284.420.500
MS  - Cytoplasmic hyaline inclusions in HEPATOCYTES. They are associated with ALCOHOLIC STEATOHEPATITIS and non-alcoholic STEATOHEPATITIS, but are also present in benign and malignant hepatocellular neoplasms, and metabolic, toxic, and chronic cholestatic LIVER DISEASES.
HN  - 2012

MH  - Mammaglobin A
UI  - D060785
MN  - D12.776.861.249
MN  - D23.101.840.425
MS  - A secretoglobin that is produced by the MAMMARY GLAND of HUMANS and may be involved in the binding of ANDROGENS and other STEROIDS. The expression of this protein in normal breast epithelium and in human breast cancer has made it an important histological marker.
HN  - 2012(1996)
BX  - Mammaglobin-A

MH  - Mammaglobin B
UI  - D060788
MN  - D12.776.861.260
MS  - A MAMMAGLOBIN A-related secretoglobin that is expressed in several HUMAN tissues including the UTERUS; BREAST; SALIVARY GLAND; and LACRIMAL GLAND.
HN  - 2012; for LIPOPHILIN-C use SECRETOGLOBINS 2001-2011, for LACRYGLOBIN, MAMMAGLOBIN-B, and MAMMAGLOBIN-1 use SECRETOGLOBINS 2009-2011
BX  - Mammaglobin-B
BX  - Secretoglobin family 2A member 1

MH  - Masked Hypertension
UI  - D059468
MN  - C14.907.489.861
MS  - Phenomenon where increased BLOOD PRESSURE readings taken in non-clinical settings (e.g., HOME BLOOD PRESSURE MONITORING) do not replicate in clinical settings.
HN  - 2012

MH  - Mastodynia
UI  - D059373
MN  - C10.597.617.205
MN  - C23.888.592.612.331
MN  - F2.830.816.308
MN  - G11.561.600.810.308
MS  - Pain in the breast generally classified as cyclical (associated with menstrual periods), or noncyclical, i.e. originating from the breast or nearby muscles or joints, ranging from minor discomfort to severely incapacitating.
HN  - 2012
BX  - Mastalgia

MH  - Mechanical Thrombolysis
UI  - D061185
MN  - E2.631
MN  - E4.100.814.842.500
MS  - Procedures to cause the disintegration of THROMBI by physical interventions.
AN  - coordinate with disease/ ther
HN  - 2012
FX  - Thrombolytic Therapy

MH  - Medical Chaperones
UI  - D061348
MN  - M1.526.485.500
MS  - Individuals who are present as a third party during medical encounters such as physical examination by a healthcare professional of an individual of the opposite sex.
HN  - 2012

MH  - Memory, Episodic
UI  - D061212
MN  - F2.463.425.540.254
MS  - Type of declarative memory, consisting of personal memory in contrast to general knowledge.
HN  - 2012; use MENTAL RECALL 2010-2011
BX  - Episodic Memory

MH  - Merkel cell polyomavirus
UI  - D059965
MN  - B4.280.640.615.550
MS  - A species of POLYOMAVIRUS suspected to be the cause of most cases of MERKEL CELL CARCINOMA, a rare but highly lethal form of skin cancer.
AN  - infection: coordinate IM with POLYOMAVIRUS INFECTIONS (IM) + TUMOR VIRUS INFECTIONS + CARCINOMA, MERKEL CELL if pertinent
HN  - 2012

MH  - Mesenchymal Stromal Cells
UI  - D059630
MN  - A11.329.830.500
MS  - Bone-marrow-derived, non-hematopoietic multipotential cells that support HEMATOPOETIC STEM CELLS. They have been isolated from UMBILICAL CORD BLOOD, umbilical vein subendothelium, and WHARTON JELLY.
AN  - do not confuse with MESENCHYMAL STEM CELLS; note entry term WHARTON JELLY CELLS: consider also WHARTON JELLY /cytol
HN  - 2012

MH  - Mesorhizobium
UI  - D059128
MN  - B3.660.50.600.500
MS  - A genus of gram-negative, rod-shaped bacteria in the family PHYLLOBACTERIACEAE. They are able to invade root-hairs of a wide range of plants, inciting the production of PLANT ROOT NODULES.
HN  - 2012

MH  - Metabolic Engineering
UI  - D060847
MN  - E5.240.311.249
MN  - E5.393.420.526
MN  - J1.293.69.249.249
MS  - Methods and techniques used to genetically modify cells' biosynthetic product output and develop conditions for growing the cells as BIOREACTORS.
HN  - 2012

MH  - Metastasectomy
UI  - D059146
MN  - E4.480
MS  - Surgery to remove one or more NEOPLASM METASTASES.
HN  - 2012

MH  - Microvascular Decompression Surgery
UI  - D061145
MN  - E4.188.600
MN  - E4.525.500
MS  - Surgery performed to relieve pressure from MICROVESSELS that are located around nerves and are causing NERVE COMPRESSION SYNDROMES.
HN  - 2012

MH  - Mild Cognitive Impairment
UI  - D060825
MN  - F3.87.250.700
MS  - A prodromal phase of cognitive decline that may precede the emergence of ALZHEIMER DISEASE and other dementias. It may include impairment of cognition, such as impairments in language, visuospatial awareness, ATTENTION and MEMORY.
HN  - 2012

MH  - Mirror Neurons
UI  - D059167
MN  - A8.663.500
MN  - A11.671.487
MS  - Neurons that fire when an animal acts or observes the same action of another thus coding the motor response. They were originally discovered in the premotor and parietal cortex of the monkey and studies have shown that neurons that have a similar mechanism are present in humans. Mirror neurons are theorized to be related to social cognition.
HN  - 2012

MH  - Morpholinos
UI  - D060172
MN  - D3.383.533.640.562
MN  - D13.695.578.424.337
MS  - Synthetic analogs of NUCLEIC ACIDS composed of morpholine ring derivatives (MORPHOLINES) linked by phosphorodimidates. One standard DNA nucleic acid base (ADENINE; GUANINE; CYTOSINE; OR THYMINE) is bound to each morpholine ring.
HN  - 2012
FX  - Oligonucleotides, Antisense

MH  - Mortality, Premature
UI  - D061213
MN  - E5.318.308.985.550.800
MN  - L1.280.975.550.800
MN  - N1.224.935.698.782
MN  - N6.850.505.400.975.550.800
MN  - N6.850.520.308.985.550.800
MS  - Deaths that occur before LIFE EXPECTANCY is reached within a given population.
HN  - 2012; use Mortality 1995-2011
BX  - Death, Premature
BX  - Premature Death
BX  - Premature Mortality
FX  - Life Expectancy

MH  - Multidetector Computed Tomography
UI  - D061330
MN  - E1.370.350.350.810.800.500
MN  - E1.370.350.600.350.700.810.800.500
MN  - E1.370.350.700.700.810.800.500
MN  - E1.370.350.700.810.810.800.249
MN  - E1.370.350.825.810.810.800.249
MS  - Types of spiral computed tomography technology in which multiple slices of data are acquired simultaneously improving the resolution over single slice acquisition technology.
HN  - 2012

MH  - Multiplex Polymerase Chain Reaction
UI  - D060885
MN  - E5.393.620.500.487
MS  - Methods for using more than one primer set in a polymerase chain reaction to amplify more than one segment of the target DNA sequence in a single reaction.
HN  - 2012

MH  - Musculoskeletal Pain
UI  - D059352
MN  - C10.597.617.231
MN  - F2.830.816.353
MN  - G11.561.600.810.353
MS  - Discomfort stemming from muscles, ligaments, tendons, and bones.
HN  - 2012

MH  - Mutation Rate
UI  - D059645
MN  - G5.355.44.250.750
MN  - G5.365.590.612
MN  - G16.100.178.250.750
MS  - The number of mutations that occur in a specific sequence, GENE, or GENOME over a specified period of time such as years, CELL DIVISIONS, or generations.
HN  - 2012

MH  - Nacre
UI  - D060734
MN  - D1.146.275.500
MN  - D1.200.275.150.150.500
MN  - D1.578.200.500
MS  - A biomineral consisting of layers of crystalized ARAGONITE, separated by interlamellar layers of organic matrix containing beta-CHITIN, and surrounded by an intercrystalline organic membrane of silk fibroin. Nacre is the iridescent substance better known as mother-of-pearl that is secreted by MOLLUSCS.
AN  - NACRE PROTEIN, ZEBRAFISH is also available
HN  - 2012

MH  - NADP Transhydrogenase, AB-Specific
UI  - D061087
MN  - D8.811.682.608.540.500
MS  - A NADP transhydrogenase subtype found in certain types of BACTERIA and mammalian MITOCHONDRIA. This transhydrogenase uses a mechanism that can transfer hydrogen to either side, A or B, of the NAD(+) or NADP(+) ring structure. In heart mitochondria, the enzyme is A-specific with respect to NAD(+) and B-specific with respect to NADP(+).
HN  - 2012

MH  - NADP Transhydrogenase, B-Specific
UI  - D061086
MN  - D8.811.682.608.540.750
MN  - D12.776.97.541
MS  - A NADP transhydrogenase subtype found in certain types of BACTERIA. This transhydrogenase uses a mechanism that transfers hydrogen to the B side of the NAD(+) or NADP(+) ring structure.
HN  - 2012

MH  - Nasal Septal Perforation
UI  - D061270
MN  - C8.460.595
MN  - C9.603.588
MN  - C26.670
MS  - An opening or hole in the NASAL SEPTUM that is caused by TRAUMA, injury, drug use, or pathological process.
HN  - 2012

MH  - Nasal Surgical Procedures
UI  - D059747
MN  - E4.580.392
MS  - Surgical operations on the nose and nasal cavity.
AN  - for transnasal or endonasal surgery performed on areas of the body reached through the nose use NATURAL ORIFICE ENDOSCOPIC SURGERY
HN  - 2012

MH  - Nasolabial Fold
UI  - D060052
MN  - A1.456.505.682
MS  - A skin crease on each side of the face that runs from the outer corners of the nose to the corner of the mouth. It is a common site of PLASTIC SURGERY.
HN  - 2012

MH  - Natural Springs
UI  - D060985
MN  - G1.311.355.750
MS  - Water that emerges to the surface of the earth from underground.
HN  - 2012
FX  - Mineral Waters

MH  - Neanderthals
UI  - D059125
MN  - B1.50.150.900.649.801.400.112.400.550
MS  - Common name for an extinct species of the Homo genus. Fossils have been found in Europe and Asia. Genetic evidence suggests that limited interbreeding with modern HUMANS (Homo sapiens) took place.
AN  - check the tag ANIMAL
HN  - 2012
BX  - Homo neanderthalensis

MH  - Neoplasm Grading
UI  - D060787
MN  - E1.789.612
MS  - Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.
AN  - IM general only; coordinate NIM with no qualifers with neoplasm terms/pathol (IM); do not confuse with NEOPLASM STAGING; grading is given in Arabic numerals, staging in Roman numerals
HN  - 2012
FX  - Nomograms

MH  - Neoplasm Micrometastasis
UI  - D061206
MN  - C4.697.650.695
MN  - C23.550.727.650.695
MS  - Newly arising secondary tumors so small they are difficult to detect by physical examination or routine imaging techniques.
HN  - 2012

MH  - Neuroimaging
UI  - D059906
MN  - E1.370.350.578
MN  - E1.370.376.537
MN  - E5.629
MS  - Non-invasive methods of visualizing the CENTRAL NERVOUS SYSTEM, especially the brain, by various imaging modalities.
AN  - coordinate with specific imaging modality if appropriate
HN  - 2012

MH  - Nociception
UI  - D059225
MN  - F2.463.593.504.500
MS  - Sensing of noxious mechanical, thermal or chemical stimuli by NOCICEPTORS. It is the sensory component of visceral and tissue pain (NOCICEPTIVE PAIN).
AN  - NOCICEPTIVE PAIN is also available
HN  - 2012

MH  - Nociceptive Pain
UI  - D059226
MN  - C10.597.617.735
MN  - C23.888.592.612.720
MN  - C23.888.646.511
MS  - Dull or sharp aching pain caused by stimulated NOCICEPTORS due to tissue injury, inflammation or diseases. It can be divided into somatic or tissue pain and VISCERAL PAIN.
AN  - NOCICEPTION is also available
HN  - 2012

MH  - Nonsense Mediated mRNA Decay
UI  - D059365
MN  - G2.111.87.750.112
MN  - G2.111.780.500
MN  - G2.149.115.750.112
MN  - G3.495.839.112
MN  - G5.355.315.700.112
MS  - An mRNA metabolic process that distinguishes a normal STOP CODON from a premature stop codon (NONSENSE CODON) and facilitates rapid degradation of aberrant mRNAs containing premature stop codons.
HN  - 2012
FX  - RNA Cleavage

MH  - Nucleoside Diphosphate Kinase D
UI  - D061107
MN  - D8.811.913.696.650.550.200.500
MN  - D12.776.575.781
MS  - A nucleoside diphosphate kinase subtype that is localized to the intermembrane space of MITOCHONDRIA.  It is believed to play a role in the synthesis of triphosphonucleotides using ATP formed through OXIDATIVE PHOSPHORYLATION.
HN  - 2012; use NM23 NUCLEOSIDE DIPHOSPHATE KINASES 2004-2011

MH  - Nucleotide Motifs
UI  - D059372
MN  - G2.111.570.80.611
MN  - G2.111.570.790.486.662
MN  - G5.360.80.611
MN  - G5.360.580.662
MS  - Commonly observed BASE SEQUENCE or nucleotide structural components which can be represented by a CONSENSUS SEQUENCE or a SEQUENCE LOGO.
HN  - 2012
FX  - Regulatory Sequences, Nucleic Acid

MH  - Numbers Needed To Treat
UI  - D061366
MN  - E5.581.500.577
MN  - E5.581.500.902.500
MS  - Number of patients who need to be treated in order to prevent one additional bad outcome. It is the inverse of Absolute Risk Reduction.
HN  - 2012

MH  - Obsessive Hoarding
UI  - D060845
MN  - F3.80.600.500
MS  - Persistent difficulty discarding or parting with possessions, regardless of the value of these possessions. Epidemiological studies suggest that hoarding occurs in 2-5% of the population and can lead to substantial distress and disability, as well as serious public health consequences.
HN  - 2012
BX  - Hoarding

MH  - Occupational Injuries
UI  - D060051
MN  - C26.716
MS  - Injuries sustained from incidents in the course of work-related activities.
AN  - coordinate IM with specific occupation (IM) and specific injury (IM) if pertinent
HN  - 2012
FX  - Accidents, Occupational

MH  - Oculomotor Nerve Injuries
UI  - D061220
MN  - C10.292.262.656
MN  - C10.292.562.700.500
MN  - C10.292.600.600
MN  - C10.900.300.218.456
MN  - C11.590.436.600
MN  - C26.260.237.527
MN  - C26.915.300.400.518
MS  - Traumatic injuries to the OCULOMOTOR NERVE. This may result in various eye movement dysfunction.
HN  - 2012
BX  - Oculomotor Nerve Injury

MH  - Oil and Gas Fields
UI  - D061329
MN  - G1.311.687
MS  - Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.
HN  - 2012
FX  - Gas, Natural
FX  - Petroleum

MH  - Olfactory Nerve Injuries
UI  - D061219
MN  - C10.292.262.687
MN  - C10.292.650.600
MN  - C10.900.300.218.487
MN  - C26.260.237.568
MN  - C26.915.300.400.562
MS  - Traumatic injuries to the OLFACTORY NERVE. It may result in various olfactory dysfunction including a complete loss of smell.
HN  - 2012
BX  - Olfactory Nerve Injury

MH  - Ophthalmoplegic Migraine
UI  - D060486
MN  - C10.228.140.546.399.750.725
MN  - C10.292.562.750.375
MN  - C10.292.675
MN  - C10.314.687
MN  - C10.597.622.447.600
MN  - C11.590.472.375
MN  - C23.888.592.636.447.600
MS  - Childhood-onset of recurrent headaches with an oculomotor cranial nerve palsy. Typically, ABDUCENS NERVE; OCULOMOTOR NERVE; and TROCHLEAR NERVE are involved with DIPLOPIA and BLEPHAROPTOSIS.
HN  - 2012

MH  - Organ Sparing Treatments
UI  - D059351
MN  - E2.674
MS  - Techniques, procedures, and therapies carried out on diseased organs in such a way to avoid complete removal of the organ and preserve the remaining organ function.
HN  - 2012
FX  - Fertility Preservation
FX  - Organs at Risk

MH  - Osmometry
UI  - D061286
MN  - E5.196.690
MS  - Measurement of the OSMOLARITY of solutions or BODY FLUIDS.
HN  - 2012

MH  - Osteology
UI  - D059166
MN  - H1.158.100.720
MS  - The branch of anatomy that concerns the structure and function of bones.
AN  - use for the discipline (education, history, etc) only
HN  - 2012
FX  - Orthopedics

MH  - Osteotomy, Sagittal Split Ramus
UI  - D059229
MN  - E4.545.637
MN  - E4.555.580.790
MN  - E6.645.637
MS  - Sagittal sectioning and repositioning of the ramus of the MANDIBLE to correct a mandibular retrusion (Malocclusion, Angle Class III) and PROGNATHISM. The oblique sectioning line consists of multiple cuts horizontal and vertical to the mandibular ramus.
HN  - 2012

MH  - Otomycosis
UI  - D059249
MN  - C1.703.658
MN  - C9.218.736
MS  - Fungus infection of the external ear, usually by ASPERGILLUS species
AN  - coordinate IM with specific fungal disease (IM) if pertinent
HN  - 2012
FX  - Otitis Externa

MH  - Pain Management
UI  - D059408
MN  - E2.745
MN  - N4.590.607.500
MS  - A form of therapy that employs a coordinated and interdisciplinary approach for easing the suffering and improving the quality of life of those experiencing pain.
HN  - 2012
FX  - Chronic Disease

MH  - Paraneoplastic Syndromes, Ocular
UI  - D059545
MN  - C4.588.364.738
MN  - C4.730.356
MN  - C11.319.466
MS  - Ocular manifestations secondary to various NEOPLASMS in which antibodies to antigens of the primary tumor cross-react with ocular antigens. This autoimmune response often leads to visual loss and other ocular dysfunctions.
HN  - 2012
FX  - Recoverin

MH  - Parasite Load
UI  - D059208
MN  - E1.370.225.932
MN  - E5.200.932
MS  - Measure of the number of the PARASITES present in a host organism.
HN  - 2012
FX  - Colony Count, Microbial
FX  - Parasites

MH  - Pasteurization
UI  - D061352
MN  - J1.576.423.200.850
MN  - J1.576.423.850.700.700
MS  - Treatment of food with physical methods such as heat, high pressure, radiation, or electric current to destroy organisms that cause disease or food spoilage.
HN  - 2012
FX  - Sterilization

MH  - Patient Safety
UI  - D061214
MN  - N6.850.135.60.75.399
MS  - Efforts to reduce risk, to address and reduce incidents and accidents that may negatively impact healthcare consumers.
HN  - 2012

MH  - Pedobacter
UI  - D060485
MN  - B3.140.600
MN  - B3.440.400.425.611
MS  - A genus of gram-negative, aerobic, rod-shaped bacteria in the family Sphingobacteriaceae. They exhibit gliding motility.
HN  - 2012

MH  - Pelvic Floor Disorders
UI  - D059952
MN  - C12.483
MN  - C13.351.625
MN  - C13.703.565
MS  - Injury, weakening, or PROLAPSE of the pelvic muscles, surrounding connective tissues or ligaments (PELVIC FLOOR).
HN  - 2012

MH  - Pelvic Girdle Pain
UI  - D059388
MN  - C10.597.617.231.500
MN  - C23.888.646.587.625
MS  - Discomfort associated with the bones that make up the pelvic girdle. It occurs frequently during pregnancy.
HN  - 2012

MH  - Performance Anxiety
UI  - D060805
MN  - F1.470.132.650
MS  - Anxiety related to the execution of a task.  (Campbell's Psychiatric Dictionary, 9th ed.)
HN  - 2012

MH  - Peripheral Nerve Injuries
UI  - D059348
MN  - C10.668.829.712
MN  - C10.900.575
MN  - C26.915.650
MS  - Injuries to the PERIPHERAL NERVES.
AN  - coordinate IM with specific peripheral nerve/ inj (IM) but note CRANIAL NERVE INJURIES and specifics are available
HN  - 2012
BX  - Peripheral Nerve Injury

MH  - Peripheral Tolerance
UI  - D061166
MN  - G12.425.746.425.800.600
MS  - The mechanism, in peripheral lymphoid organs (LYMPH NODES; SPLEEN; TONSILS; and mucosal-associated lymphoid tissue), that prevents mature lymphocytes from reacting to SELF-ANTIGENS. This is accomplished through a variety of means including CLONAL ANERGY and CLONAL DELETION.
HN  - 2012

MH  - Peroxiredoxin III
UI  - D061105
MN  - D8.811.682.732.850.249
MN  - D12.776.575.812
MS  - A THIOREDOXIN-dependent hydroperoxidase that is localized in the mitochondrial matrix. The enzyme plays a crucial role in protecting mitochondrial components from elevated levels of HYDROGEN PEROXIDE.
HN  - 2012; use PEROXIREDOXINS 2003-2011

MH  - Petroleum Pollution
UI  - D059392
MN  - N6.850.460.660
MS  - Release of oil into the environment usually due to human activity.
HN  - 2012
BX  - Oil Pollution
BX  - Oil Spills

MH  - Petrositis
UI  - D059270
MN  - C1.539.160.495.750
MN  - C5.116.165.495.500
MN  - C9.218.705.663.841
MS  - Inflammation of PETROUS BONE.
HN  - 2012; for GRADENIGO'S SYNDROME see under OTITIS MEDIA 1963-81, use OTITIS MEDIA 1982-92

MH  - Phaeohyphomycosis
UI  - D060446
MN  - C1.539.800.200.637
MN  - C1.703.295.637
MN  - C1.703.726
MN  - C17.800.838.208.637
MS  - OPPORTUNISTIC INFECTIONS caused by the dematiaceous (darkly pigmented) MITOSPORIC FUNGI of ALTERNARIA, Bipolaris, CLADOSPORIUM, Curvularia, and EXOPHIALA. These fungi have pigmented HYPHAE due to MELANIN in the cell wall. The initial subcutaneous cyst from the infection can become systemic and spread rapidly to renal, pulmonary and cerebral systems (see CEREBRAL PHAEOHYPHOMYCOSIS) in an IMMUNOCOMPROMISED HOST.
HN  - 2012
BX  - Subcutaneous Phaeohyphomycosis

MH  - Pharmaceutical Services, Online
UI  - D060946
MN  - N2.421.668.475
MS  - Pharmacy services accessed via electronic means.
HN  - 2012
FX  - Pharmacies

MH  - Pharmacovigilance
UI  - D060735
MN  - E5.337.800.600
MN  - L1.453.270.600
MN  - N6.850.505.636
MS  - The detection of long and short term side effects of conventional and traditional medicines through research, data mining, monitoring, and evaluation of healthcare information obtained from healthcare providers and patients.
HN  - 2012
FX  - Drug Monitoring

MH  - Phonons
UI  - D060739
MN  - G1.249.675
MN  - G1.750.770.776.783
MS  - Quanta of acoustic energy which move at the speed of sound.
HN  - 2012

MH  - Photoacoustic Techniques
UI  - D061088
MN  - E1.370.565
MN  - E5.696
MS  - Investigative and diagnostic methods and procedures based on the photoacoustic effect, which is the generation of SOUND WAVES from the absorption of ELECTROMAGNETIC RADIATION.
AN  - coordinate with specific investigative or diagnostic technique (DIAGNOSTIC IMAGING; MICROSCOPY; TOMOGRAPHY; etc.) if pertinent
HN  - 2012

MH  - Phyllobacteriaceae
UI  - D059127
MN  - B3.660.50.600
MS  - Family of gram-negative bacteria that occur in leaf nodules and the rhizosphere of higher plants.
HN  - 2012

MH  - Physical Therapists
UI  - D059825
MN  - M1.526.485.67.737
MN  - N2.360.67.735
MS  - Persons trained in PHYSICAL THERAPY (SPECIALTY) to make use of PHYSICAL THERAPY MODALITIES to prevent, correct, and alleviate movement dysfunction of anatomic or physiologic origin.
HN  - 2012

MH  - Piezosurgery
UI  - D059745
MN  - E4.943.937
MS  - The use of HIGH-ENERGY SHOCK WAVES, in the frequency range of 20-30 kHz, to cut through mineralized tissue.
HN  - 2012

MH  - Pinguecula
UI  - D059407
MN  - C11.187.631
MS  - A yellowish thickened lesion on the conjunctiva near the CORNEA representing a benign degenerative change in the CONJUNCTIVA caused by the leakage and deposition of certain blood proteins through the permeable capillaries near the LIMBUS.
HN  - 2012

MH  - Planctomycetales
UI  - D061328
MN  - B3.440.614
MN  - B3.650
MS  - A phylum of gram-negative bacteria whose members are found in a variety of water habitats as well as animal tissues.
HN  - 2012

MH  - Plant Cells
UI  - D059828
MN  - A11.562
MS  - Basic functional unit of plants.
AN  - General or unspecified. prefer specific plant with /cytol.
HN  - 2012

MH  - Plant Pathology
UI  - D061066
MN  - H1.158.273.200.675
MN  - H1.158.273.540.706
MS  - The study of infectious diseases associated with plants.
AN  - the discipline (education, history, etc) only; use PLANT DISEASES for diseases in plants; use PLANTS /microbiol or /virol for microbiologic or virologic studies of plants and do not index here
HN  - 2012

MH  - Plyometric Exercise
UI  - D059385
MN  - E2.779.483.812
MN  - E2.831.387.812
MN  - G11.427.590.530.698.277.374
MN  - I3.350.374
MS  - Exercises in which muscles are repeatedly and rapidly stretched, followed by shortening, concentric MUSCLE CONTRACTION (e.g. jumping and rebounding). They are designed to exert maximal force in minimal time by increasing STRETCH REFLEX.
HN  - 2012

MH  - Polar Bodies
UI  - D059705
MN  - A5.360.490.690.680.500
MN  - A11.497.497.600.500
MS  - Minute cells produced during development of an OOCYTE as it undergoes MEIOSIS. A polar body contains one of the nuclei derived from the first or second meiotic CELL DIVISION. Polar bodies have practically no CYTOPLASM. They are eventually discarded by the oocyte. (from King & Stansfield, A Dictionary of Genetics, 4th ed)
HN  - 2012

MH  - Polydipsia
UI  - D059606
MN  - C23.550.759
MN  - C23.888.663
MS  - Excessive thirst manifested by excessive fluid intake. It is characteristic of many diseases such as DIABETES MELLITUS; DIABETES INSIPIDUS; and NEPHROGENIC DIABETES INSIPIDUS. The condition may be psychogenic in origin.
AN  - Do not confuse with POLYDIPSIA, PSYCHOGENIC
HN  - 2012
FX  - Thirst

MH  - Polydipsia, Psychogenic
UI  - D059607
MN  - C23.550.759.500
MN  - C23.888.663.500
MN  - F1.145.126.968
MN  - F1.700.812
MS  - A clinical disorder characterized by excessive fluid intake (polydipsia); HYPONATREMIA; and POLYURIA in SCHIZOPHRENIA and other psychiatric disorders. Impaired water metabolism in psychogenic polydipsia can result in WATER INTOXICATION.
AN  - Do not confuse with POLYDIPSIA
HN  - 2012

MH  - Polyketides
UI  - D061065
MN  - D2.540.576
MN  - D4.345.674
MS  - Natural compounds containing alternating carbonyl and methylene groups (beta-polyketones), bioenergenetically derived from repeated condensation of acetyl coenzyme A via malonyl coenzyme A, in a process similar to fatty acid synthesis.
HN  - 2012

MH  - Polyphenols
UI  - D059808
MN  - D2.755.715
MN  - D3.438.150.266.450.260.777
MS  - A large class of organic compounds having more than one PHENOL group.
HN  - 2012 (2010)

MH  - Ponds
UI  - D061005
MN  - G1.311.718
MN  - G16.500.275.280.625
MN  - N6.230.232.625
MS  - Inland bodies of standing FRESHWATER usually smaller than LAKES. They can be man-made or natural but there is no universal agreement as to their exact size. Some consider a pond to be a small body of water that is shallow enough for sunlight to reach the bottom.
AN  - do not use for salt ponds
HN  - 2012

MH  - Positron-Emission Tomography and Computed Tomography
UI  - D059628
MN  - E1.370.350.350.800.700.500
MN  - E1.370.350.350.810.645
MN  - E1.370.350.600.350.700.810.490
MN  - E1.370.350.600.350.800.399.500
MN  - E1.370.350.700.700.810.645
MN  - E1.370.350.700.810.810.722
MN  - E1.370.350.710.800.399.500
MN  - E1.370.350.825.800.399.500
MN  - E1.370.350.825.810.810.699
MN  - E1.370.384.730.800.399.500
MS  - Techniques for the combination of overlapping POSITRON-EMISSION TOMOGRAPHY and X-RAY COMPUTED TOMOGRAPHY images.
AN  - coordinate with disease /radionuclide or anatomical term / radionuclide
HN  - 2012

MH  - Postsynaptic Potential Summation
UI  - D059227
MN  - G2.111.87.800.850.500
MN  - G2.149.115.800.850.500
MN  - G4.299.880.850.500
MN  - G4.580.887.750
MN  - G7.265.337.900.750.780
MN  - G7.265.750.887.750
MN  - G7.700.240.900.750.780
MN  - G11.561.570.918.750
MN  - G11.561.600.835.750.780
MS  - Physiological integration of multiple SYNAPTIC POTENTIAL signals to reach the threshold and initiate postsynaptic ACTION POTENTIALS. In spatial summation stimulations from additional synaptic junctions are recruited to generate s response. In temporal summation succeeding stimuli signals are summed up to reach the threshold. The postsynaptic potentials can be either excitatory or inhibitory (EPSP or IPSP).
HN  - 2012
BX  - Neurophysiology Summation

MH  - Potassium Ionophores
UI  - D061216
MN  - D27.505.519.562.374.400
MN  - D27.720.395.400
MS  - Chemical agents that increase the permeability of CELL MEMBRANES to POTASSIUM ions.
HN  - 2012

MH  - Pott Puffy Tumor
UI  - D059369
MN  - C1.539.160.495.875
MN  - C5.116.165.495.750
MN  - C11.675.689
MS  - Infection of the FRONTAL BONE often as a complication of FRONTAL SINUSITIS or trauma to the frontal bone and skull. It is characterized by subperiosteal abscess with OSTEOMYELITIS.
AN  - do not confuse with POTT DISEASE see TUBERCULOSIS, SPINAL
HN  - 2012
FX  - Tuberculosis, Spinal

MH  - Pregnancy, Quadruplet
UI  - D059287
MN  - G8.686.710.30
MS  - The condition of carrying QUADRUPLETS simultaneously.
AN  - human only; for animals, use PREGNANCY, MULTIPLE, but see note there; QUADRUPLETS is also available for the offspring; check tags FEMALE & PREGNANCY
HN  - 2012

MH  - Pregnancy, Quintuplet
UI  - D059288
MN  - G8.686.710.62
MS  - The condition of carrying QUINTUPLETS simultaneously.
AN  - human only; for animals, use PREGNANCY, MULTIPLE, but see note there; QUINTUPLETS is also available for the offspring; check tags FEMALE & PREGNANCY
HN  - 2012

MH  - Pregnancy, Triplet
UI  - D059286
MN  - G8.686.710.126
MS  - The condition of carrying TRIPLETS simultaneously.
AN  - human only; for animals, use PREGNANCY, MULTIPLE, but see note there; TRIPLETS is also available for the offspring; check tags FEMALE & PREGNANCY
HN  - 2012

MH  - Pregnancy, Twin
UI  - D059285
MN  - G8.686.710.253
MS  - The condition of carrying TWINS simultaneously.
AN  - human only; for animals, use PREGNANCY, MULTIPLE, but see note there; TWINS is also available for the offspring; check tags FEMALE & PREGNANCY
HN  - 2012

MH  - Primary Cell Culture
UI  - D061251
MN  - E1.370.225.500.223.500
MN  - E5.200.500.223.500
MN  - E5.240.249.500
MN  - E5.242.223.500
MS  - The initial culturing of cells derived directly from fresh TISSUES.
HN  - 2012; use CELL CULTURE TECHNIQUES 2005-2011

MH  - Programmed Cell Death 1 Ligand 2 Protein
UI  - D061027
MN  - D12.776.467.150.800
MN  - D12.776.543.95.800
MN  - D23.50.301.264.35.276.800
MN  - D23.50.301.285.800
MN  - D23.101.100.110.276.800
MN  - D23.529.168.800
MS  - A costimulatory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 RECEPTOR. It is closely-related to CD274 antigen; however, its expression is restricted to DENDRITIC CELLS and activated MACROPHAGES.
HN  - 2012(2001)

MH  - Programmed Cell Death 1 Receptor
UI  - D061026
MN  - D12.776.543.750.705.222.875
MN  - D23.50.301.264.35.588
MN  - D23.50.301.264.894.790
MN  - D23.101.100.110.588
MN  - D23.101.100.894.790
MS  - An inhibitory T-lymphocyte receptor that has specificity for CD274 ANTIGEN and PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN. Signaling by the receptor limits T cell proliferation and INTERFERON GAMMA synthesis. The receptor also may play an essential role in the regulatory pathway that induces PERIPHERAL TOLERANCE.
HN  - 2012
BX  - Programmed Cell Death 1 Protein

MH  - Pronephros
UI  - D060910
MN  - A16.835
MS  - The primordial kidney that develops from the INTERMEDIATE MESODERM in the embryos of vertebrates, and is succeeded by the MESONEPHROS. In higher vertebrates and humans, the pronephros is a vestigial and transient structure.
HN  - 2012

MH  - Prostatein
UI  - D060789
MN  - D12.776.861.311
MS  - A secreted prostate-specific protein which can bind non-polar steroids, cholesterol and a group of small, proline-rich peptides. The protein is specifically found in RATS and comprises three distinct secretoglobin-related subunits referred to as prostatic steroid-binding protein C1, C2 and C3.
HN  - 2012

MH  - Prosthesis Retention
UI  - D060489
MN  - E2.794.500
MS  - Holding a PROSTHESIS in place.
AN  - coordinate with specific prosthesis with no qualifiers; DENTAL PROSTHESIS RETENTION is also available
HN  - 2012
FX  - Dental Prosthesis Retention
FX  - Prostheses and Implants
FX  - Prosthesis Failure

MH  - Protein Interaction Maps
UI  - D060066
MN  - G3.495.553.750
MS  - Graphs representing sets of measurable, non-covalent physical contacts with specific PROTEINS in living organisms or in cells.
HN  - 2012; for PROTEIN INTERACTION MAPS use PROTEIN INTERACTION MAPPING 2002-2011
BX  - Protein-Protein Interaction Map
FX  - Gene Regulatory Networks
FX  - Protein Interaction Domains and Motifs
FX  - Protein Interaction Mapping

MH  - Proteolysis
UI  - D059748
MN  - G2.111.87.710
MN  - G2.149.115.710
MN  - G3.495.802
MS  - Cleavage of proteins into smaller peptides or amino acids either by PROTEASES or non-enzymatically (e.g., Hydrolysis). It does not include Protein Processing, Post-Translational.
HN  - 2012

MH  - Proton Ionophores
UI  - D061209
MN  - D27.505.519.389.936.500
MN  - D27.505.519.562.374.500
MN  - D27.720.395.500
MS  - Chemical agents that increase the permeability of CELL MEMBRANES to PROTONS.
HN  - 2012

MH  - Pudendal Nerve
UI  - D060525
MN  - A8.800.800.720.450.680
MS  - A nerve which originates in the sacral spinal cord (S2 to S4) and innervates the PERINEUM, the external GENITALIA, the external ANAL SPHINCTER and the external urethral sphincter. It has three major branches: the perineal nerve, inferior anal nerves, and the dorsal nerve of penis or clitoris.
AN  - do not confuse with PERONEAL NERVE
HN  - 2012
FX  - Peroneal Nerve

MH  - Pudendal Neuralgia
UI  - D060545
MN  - C10.597.617.682.737
MN  - C10.668.829.550.650
MN  - C10.668.829.600.737
MN  - C23.888.592.612.664.737
MN  - C23.888.646.508.737
MS  - Pain associated with a damaged PUDENDAL NERVE. Clinical features may include positional pain with sitting in the perineal and genital areas, sexual dysfunction and FECAL INCONTINENCE and URINARY INCONTINENCE.
HN  - 2012
BX  - Neuralgia, Pudendal

MH  - Pulsed Radiofrequency Treatment
UI  - D061208
MN  - E2.342.671
MN  - E2.779.468.599
MS  - The application, via IMPLANTED ELECTRODES, of short bursts of electrical energy in the radiofrequency range, interspersed with pauses in delivery of the current long enough to dissipate the generated heat and avoid heat-induced tissue necrosis.
HN  - 2012

MH  - Radiostereometric Analysis
UI  - D059869
MN  - E1.370.350.600.630.750
MN  - E1.370.350.700.750
MS  - Methods for performing three-dimensional measurement and motion analysis using stereoscopic radiographs.
HN  - 2012

MH  - Radiotherapy Setup Errors
UI  - D061106
MN  - E2.815.565
MN  - N2.421.450.800
MS  - Mistakes committed in the preparations for radiotherapy, including errors in positioning of patients, alignment radiation beams, or calculation of radiation doses.
HN  - 2012
FX  - Organs at Risk

MH  - Radiotherapy, Image-Guided
UI  - D061089
MN  - E2.815.768
MS  - The use of pre-treament imaging modalities to position the patient, delineate the target, and align the beam of radiation to achieve optimal accuracy and reduce radiation damage to surrounding non-target tissues.
HN  - 2012
FX  - Fiducial Markers
FX  - Patient Positioning

MH  - Real-Time Polymerase Chain Reaction
UI  - D060888
MN  - E5.393.620.500.706
MS  - Methods used for detecting the amplified DNA products from the polymerase chain reaction as they accumulate instead of at the end of the reaction.
AN  - RT-PCR in the literature is probably REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION not this term; check text
HN  - 2012

MH  - Receptors, Autocrine Motility Factor
UI  - D060285
MN  - D8.811.464.938.750.656
MN  - D12.776.543.750.67
MS  - Cell surface receptors for AUTOCRINE MOTILITY FACTOR, which is the secreted form of GLUCOSE-6-PHOSPHATE ISOMERASE. The receptor has an unusual composition in that it shares some structural similarities with G-PROTEIN-COUPLED RECEPTORS and functions as an ubiquitin protein ligase when internalized.
HN  - 2012(1991)

MH  - Receptors, Wnt
UI  - D060490
MN  - D12.776.543.750.962
MS  - Cell-surface receptors that specifically bind to WNT PROTEINS and activate the WNT SIGNALING PATHWAY.
HN  - 2012

MH  - Recombinational DNA Repair
UI  - D059767
MN  - G2.111.87.219.700
MN  - G2.149.115.219.700
MN  - G5.355.195.700
MN  - G5.355.760.615.612
MS  - Repair of DNA DAMAGE by exchange of DNA between matching sequences, usually between the allelic DNA (ALLELES) of sister chromatids.
HN  - 2012
BX  - Homologous Recombination DNA Repair
BX  - Homologous Recombination Repair of DNA
BX  - Homology-Directed dsDNA Break Repair

MH  - Recurrent Laryngeal Nerve Injuries
UI  - D061226
MN  - C8.360.424.500
MN  - C9.400.424.500
MN  - C10.292.262.937.750.500
MN  - C10.900.300.218.887.750.500
MN  - C26.260.237.912.750.500
MN  - C26.915.300.400.912.750.500
MS  - Traumatic injuries to the RECURRENT LARYNGEAL NERVE that may result in vocal cord dysfunction.
HN  - 2012

MH  - Reflex, Trigeminocardiac
UI  - D059230
MN  - G11.561.600.765.781
MS  - Sudden occurrence of BRADYCARDIA or HEART ARREST induced by manipulations of the MAXILLARY NERVE AND MANDIBULAR NERVE during a craniomaxillofacial or oral surgery. It is the maxillary and mandibular variants of OCULOCARDIAC REFLEX.
HN  - 2012

MH  - Remuneration
UI  - D060926
MN  - N1.824.417.605
MS  - Payment for a service or for a commodity such as a body part.
HN  - 2012; use FEES AND CHARGES 1993-2011

MH  - Renal Nutcracker Syndrome
UI  - D059228
MN  - C12.777.419.787
MN  - C13.351.968.419.787
MS  - Left RENAL VEIN compression between the AORTA, ABDOMINAL and the SUPERIOR MESENTERIC ARTERY. Variable symptoms include HYPERTENSION, RENOVASCULAR; HEMATURIA; and VARICOSE VEINS.
HN  - 2012
FX  - Superior Mesenteric Artery Syndrome

MH  - Renewable Energy
UI  - D059205
MN  - N6.230.132.644
MS  - Forms of energy that are constantly and rapidly renewed by natural processes such as solar, ocean wave, and wind energy. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
HN  - 2012

MH  - Repetition Priming
UI  - D060865
MN  - F2.463.425.540.739
MS  - A type of procedural memory manifested as a change in the ability to identify an item as a result of a previous encounter with the item or stimuli.
HN  - 2012

MH  - Reproductive Health
UI  - D060728
MN  - N1.400.625
MS  - The status of one's reproductive system and its function.
HN  - 2012; use Reproductive Medicine 1995-2011
FX  - Reproductive Medicine

MH  - Reproductive Isolation
UI  - D060047
MN  - G5.355.44.675
MN  - G16.100.178.802
MS  - Mechanisms that prevent different populations from exchanging genes (GENE FLOW), resulting in or maintaining GENETIC SPECIATION. It can either prevent mating to take place or ensure that any offspring produced is either inviable or sterile, thereby preventing further REPRODUCTION.
AN  - permitted with animals, plants and microorganisms
HN  - 2012

MH  - Reproductive Tract Infections
UI  - D060737
MN  - C1.539.730
MN  - C12.294.604
MN  - C13.351.500.630
MS  - Infections of the genital tract in females or males. They can be caused by endogenous, iatrogenic, or sexually transmitted organisms.
HN  - 2012
FX  - Sexually Transmitted Diseases

MH  - Reverse Genetics
UI  - D059386
MN  - E5.393.731
MS  - The use of techniques that produce a functional MUTATION or an effect on GENE EXPRESSION of a specific gene of interest in order to identify the role or activity of the gene product of that gene.
HN  - 2012

MH  - Riemerella
UI  - D060494
MN  - B3.140.190.700
MN  - B3.440.400.425.310.700
MS  - A genus of gram-negative, rod-shaped bacteria in the family FLAVOBACTERIACEAE that causes exudative SEPTICEMIA in ducks, pigeons, and other domestic and wild birds.
AN  - infection: coordinate IM with FLAVOBACTERIACEAE INFECTIONS (IM)
HN  - 2012

MH  - RNA Cleavage
UI  - D059367
MN  - G2.111.87.723
MN  - G2.149.115.723
MN  - G5.355.780
MS  - A reaction that severs one of the sugar-phosphate linkages of the phosphodiester backbone of RNA. It is catalyzed enzymatically, chemically, or by radiation. Cleavage may be exonucleolytic, or endonucleolytic.
HN  - 2012
FX  - Nonsense Mediated mRNA Decay
FX  - RNA Splicing
FX  - RNA Stability

MH  - RNA Folding
UI  - D059370
MN  - G1.154.100.820
MN  - G1.595.100.820
MN  - G2.111.87.736
MN  - G2.111.570.790.486.718
MN  - G2.149.115.736
MN  - G5.360.580.718
MS  - The processes of RNA tertiary structure formation.
HN  - 2012
FX  - Nucleic Acid Conformation

MH  - RNA Isoforms
UI  - D059368
MN  - D13.444.735.64
MS  - The different gene transcripts generated from a single gene by RNA EDITING or ALTERNATIVE SPLICING of RNA PRECURSORS.
HN  - 2012

MH  - Root Cause Analysis
UI  - D060891
MN  - N5.715.360.700
MS  - Multi-step systematic review process used for improving safety by investigation of incidents to find what happened, why it happened, and to determine what can be done to prevent it from happening again.
HN  - 2012

MH  - S Phase Cell Cycle Checkpoints
UI  - D059807
MN  - G4.299.134.109.875
MN  - G4.299.134.500.800.500
MS  - Cell regulatory signaling system that controls progression through S PHASE and stabilizes the replication forks during conditions that could affect the fidelity of DNA REPLICATION, such as DNA DAMAGE or depletion of nucleotide pools.
AN  - suggestion for AN: coordinate with specific process of if pertinent. for example DNA DAMAGE for "S phase DNA damage checkpoint"
HN  - 2012
BX  - S Phase Cell Cycle Checkpoint
BX  - S Phase Checkpoint

MH  - Scopulariopsis
UI  - D060645
MN  - B1.300.381.802
MS  - A mitosporic fungal genus commonly found in soil. It includes both saprophytes and animal pathogens. Scopulariopsis brevicaulis and related species may convert ARSENIC to volatile and toxic arsine. ONYCHOMYCOSIS and rarely BRAIN ABSCESS; MYCETOMA, and disseminated infections mainly in the IMMUNOCOMPROMISED HOSTS are associated with Scopulariopsis.
AN  - infection: coordinate IM with MYCOSES (IM) or specific mycosis (IM)
HN  - 2012

MH  - Secretoglobins
UI  - D060765
MN  - D12.776.861
MS  - A structurally-related family of small, multimeric proteins that are secreted in the mucosa of mammalian epithelial tissues. A variety of proteins are classed under this heading including some secretoglobin subtypes that appear unique to a particular mammalian species, and others whose functions differ between species.
HN  - 2012

MH  - Self-Incompatibility in Flowering Plants
UI  - D060436
MN  - G15.744.875
MS  - One of many different processes which occur in ANGIOSPERMS by which genetic diversity is maintained while INBREEDING is prevented.
HN  - 2012

MH  - Sense of Coherence
UI  - D060685
MN  - F1.58.788
MN  - F1.752.747.792.925
MS  - A view of the world and the individual's environment as comprehensible, manageable, and meaningful, claiming that the way people view their life has a positive influence on their health.
HN  - 2012

MH  - Serotonergic Neurons
UI  - D059326
MN  - A8.663.895
MN  - A11.671.895
MS  - Neurons whose primary neurotransmitter is SEROTONIN.
HN  - 2012

MH  - Sex Workers
UI  - D060386
MN  - M1.776
MS  - People who engage in occupational sexual behavior in exchange for economic rewards or other extrinsic considerations.
HN  - 2012

MH  - Signal-To-Noise Ratio
UI  - D059629
MN  - E5.318.740.872.875
MN  - E5.318.780.800.875
MN  - G17.800.500
MN  - N5.715.360.750.725.750
MN  - N5.715.360.780.700.840
MN  - N6.850.520.445.800.875
MN  - N6.850.520.830.872.750
MS  - The comparison of the quantity of meaningful data to the irrelevant or incorrect data.
HN  - 2012

MH  - Sinus Floor Augmentation
UI  - D059546
MN  - E4.545.668
MN  - E4.555.130.550
MN  - E6.645.668
MS  - Guided BONE TRANSPLANTATION of the MAXILLARY SINUS surface with a BONE SUBSTITUTE grafting. It increases the bone volume at the site of the DENTAL IMPLANT and helps stabilize it.
HN  - 2012

MH  - Slipped Capital Femoral Epiphyses
UI  - D060048
MN  - C5.116.99.708.928
MN  - C5.116.425.500
MS  - A developmental deformity in which the metaphysis of the FEMUR moves proximally and anteriorly away from FEMUR HEAD (epiphysis) at the upper GROWTH PLATE. It is most common in male adolescents and is associated with a greater risk of early OSTEOARTHRITIS of the hip.
HN  - 2012
BX  - Slipped Capital Femoral Epiphysis
FX  - Coxa Vara

MH  - Social Media
UI  - D061108
MN  - L1.224.230.110.500.750
MS  - Platforms that provide the ability and tools to create and publish information accessed via the INTERNET. Generally these platforms have three characteristics with content user generated, high degree of interaction between creator and viewer, and easily integrated with other sites.
HN  - 2012

MH  - Social Networking
UI  - D060756
MN  - F1.145.209.818
MN  - L1.143.910
MS  - Individuals connecting by family, work or other interests. It also includes connectivity facilitated by computer-based communications.
AN  - do not confuse with SOCIAL NETWORKS see SOCIAL SUPPORT
HN  - 2012

MH  - Sodium Ionophores
UI  - D061210
MN  - D27.505.519.562.374.750
MN  - D27.720.395.750
MS  - Chemical agents that increase the permeability of CELL MEMBRANES to SODIUM ions.
HN  - 2012

MH  - Sodium-Coupled Vitamin C Transporters
UI  - D060347
MN  - D12.776.157.530.450.74.500.687.500
MN  - D12.776.157.530.450.625.405
MN  - D12.776.543.585.450.74.500.812.500
MN  - D12.776.543.585.450.625.531
MS  - Membrane transport proteins that actively co-transport ASCORBIC ACID and sodium ions across the CELL MEMBRANE. Dietary absorption of VITAMIN C is highly dependent upon this class of transporters and a subset of SODIUM GLUCOSE TRANSPORTERS which transport the oxidized form of vitamin C, DEHYDROASCORBIC ACID.
HN  - 2012(1999)

MH  - Solid-Phase Synthesis Techniques
UI  - D060327
MN  - E5.916.39.500
MN  - E5.916.840
MN  - G2.607.750.155.500
MN  - J1.897.836.249.500
MS  - Techniques used to synthesize chemicals using molecular substrates that are bound to a solid surface. Typically a series of reactions are conducted on the bound substrate that results in either the covalent attachment of specific moieties or the modification of existing function groups. These techniques offer an advantage to those involving solution reactions in that the substrate compound does not have to be isolated and purified between the reaction steps.
HN  - 2012
BX  - Solid-Phase Synthesis

MH  - Sphenopalatine Ganglion Block
UI  - D059387
MN  - E3.155.86.711.299.500
MN  - E4.525.210.550.500.500
MS  - Method of treating pain associated with the sphenopalatine ganglion located in the PTERYGOPALATINE FOSSA, posterior to the middle nasal turbinate. The transnasal approach involves application of suitable local anesthetic to the mucous membrane overlying the ganglion.
HN  - 2012

MH  - Stereocilia
UI  - D059547
MN  - A11.284.180.800
MS  - Mechanosensing organelles of hair cells which respond to fluid motion or fluid pressure changes. They have various functions in many different animals, but are primarily used in hearing.
HN  - 2012
FX  - Hair Cells, Ampulla
FX  - Hair Cells, Auditory
FX  - Hair Cells, Auditory, Inner
FX  - Hair Cells, Auditory, Outer
FX  - Hair Cells, Vestibular

MH  - Stroke, Lacunar
UI  - D059409
MN  - C10.228.140.300.275.800
MN  - C10.228.140.300.775.600
MN  - C14.907.253.329.800
MN  - C14.907.253.855.600
MS  - Stroke caused by lacunar infarction or other small vessel diseases of the brain. It features hemiparesis (see PARESIS), hemisensory, or hemisensory motor loss.
HN  - 2012; for Infarction, Lacunar use BRAIN INFARCTION 2000-2011
BX  - Infarction, Lacunar

MH  - Sun Protection Factor
UI  - D059405
MN  - E5.196.867.917
MN  - E5.799.890
MS  - A measure of relative protection provided by SUNSCREENING AGENTS against burns due to ultraviolet (UV) radiation from a light source.
HN  - 2012
FX  - Sunscreening Agents

MH  - Support Vector Machines
UI  - D060388
MN  - L1.224.50.500
MN  - L1.224.65.815
MN  - L1.725.750
MS  - Learning algorithms which are a set of related supervised computer learning methods that analyze data and recognize patterns, and used for classification and regression analysis.
HN  - 2012

MH  - Supraglottitis
UI  - D059525
MN  - C8.360.840
MN  - C8.730.798
MN  - C9.400.840
MS  - Inflammation of the EPIGLOTTIS and supraglottic structures including the PHARYNX; UVULA; base of tongue; and aryepiglottic folds. It is usually caused by HAEMOPHILUS INFLUENZAE in children but often by different organisms in adults.
HN  - 2012

MH  - Sympatry
UI  - D061350
MN  - G5.910
MS  - In evolutionary theory, overlapping geographic distribution of diverging species. In sympatric GENETIC SPECIATION, genetic diversion occurs without geographic separation.
AN  - for sympatric speciation, coordinate with GENETIC SPECIATION
HN  - 2012

MH  - Tachypnea
UI  - D059246
MN  - C8.618.961
MN  - C23.888.852.944
MS  - Increased RESPIRATORY RATE.
HN  - 2012

MH  - Telescopes
UI  - D061351
MN  - E7.632.875
MS  - Instruments used to observe distant objects.
HN  - 2012

MH  - Telomere Homeostasis
UI  - D059505
MN  - G4.299.134.220.625
MN  - G4.299.233.750.500.500
MN  - G5.355.105.610
MN  - G7.700.320.249.410.750.500.750
MS  - Maintenance of TELOMERE length. During DNA REPLICATION, chromosome ends loose some of their telomere sequence (TELOMERE SHORTENING.) Various cellular mechanism are involved in repairing, extending, and recapping the telomere ends.
HN  - 2012
FX  - Telomerase
FX  - Telomere Shortening
FX  - Telomere-Binding Proteins

MH  - Telomere Shortening
UI  - D059506
MN  - G2.111.87.222.940
MN  - G2.149.115.222.940
MN  - G4.299.119.630
MN  - G5.355.200.940
MS  - The loss of some TELOMERE sequence during DNA REPLICATION of the first several base pairs of a linear DNA molecule; or from DNA DAMAGE. Cells have various mechanisms to restore length (TELOMERE HOMEOSTASIS.) Telomere shortening is involved in the progression of CELL AGING.
HN  - 2012
FX  - Telomere Homeostasis

MH  - Tenacibaculum
UI  - D060493
MN  - B3.140.190.800
MN  - B3.440.400.425.310.800
MS  - A genus of gram-negative, rod-shaped bacteria in the family FLAVOBACTERIACEAE. Tenacibaculum adheres to surfaces of marine organisms and is pathogenic to fish.
AN  - infection: coordinate IM with FLAVOBACTERIACEAE INFECTIONS (IM)
HN  - 2012

MH  - Tetraspanins
UI  - D059470
MN  - D12.776.543.982
MS  - A large superfamily of cell surface membrane proteins characterized by their four transmembrane domains. They play a role in a variety of processes such as cellular adhesion and motility. They may be involved in the organization of cell surface MEMBRANE MICRODOMAINS that regulate the activation of LEUKOCYTES.
AN  - general or unspecified; prefer specifics
HN  - 2012

MH  - Text Messaging
UI  - D060145
MN  - L1.143.506.423.906.377.666
MN  - L1.178.847.698.300.500
MS  - Communication between CELL PHONE users via the Short Message Service protocol which allows the interchange of short written messages.
HN  - 2012

MH  - Therapeutic Occlusion
UI  - D060205
MN  - E2.926
MS  - Methods used to temporarily or permanently block the flow of BODY FLUIDS through various ducts and tubules throughout the body, including BLOOD VESSELS and LYMPHATIC VESSELS such as by THERAPEUTIC EMBOLIZATION or LIGATION.
HN  - 2012

MH  - Therapy with Helminths
UI  - D061147
MN  - E2.960
MS  - The treatment of immune system diseases by deliberate infestation with helminths. This therapy is partly based on the HYGIENE HYPOTHESIS which states that the absence of parasites increases immune dysregulation because of the lack of stimulation of REGULATORY T-CELLS.
HN  - 2012
BX  - Helminthic Therapy
FX  - Hygiene Hypothesis

MH  - Thylakoid Membrane Proteins
UI  - D060431
MN  - D12.776.183.750
MN  - D12.776.543.983
MN  - D12.776.765.199.750
MS  - Proteins found within the THYLAKOID MEMBRANES of photosynthetic organisms such as PLANTS and PHYTOPLANKTON. Many of the proteins in this class are involved in the process of PHOTOSYNTHESIS and the generation of ADENOSINE TRIPHOSPHATE.
HN  - 2012

MH  - Thymocytes
UI  - D060168
MN  - A11.118.637.555.567.569.360.800
MN  - A11.148.378.294.750.800
MN  - A11.872.378.294.750.800
MN  - A11.900
MS  - HEMATOPOIETIC PROGENITOR CELLS that have migrated to the THYMUS where they differentiate into T-LYMPHOCYTES. Thymocytes are classified into maturational stages based on the expression of CELL SURFACE ANTIGENS.
HN  - 2012

MH  - Thysanoptera
UI  - D061149
MN  - B1.50.500.131.617.800
MS  - An order of very small, fringed-wing INSECTS including many agricultural pests.
AN  - for killing THYSANOPTERA with insecticides, see note at INSECTICIDES
HN  - 2012

MH  - Tobacco Use Cessation Products
UI  - D061485
MN  - J1.637.847
MS  - Items used to aid in ending a TOBACCO habit.
HN  - 2012
FX  - Tobacco Use Cessation

MH  - Torso
UI  - D060726
MN  - A1.923
MS  - The central part of the body to which the neck and limbs are attached.
AN  - do not confuse with torso protein often referred to as "torso"; "trunk" in reference to the main part of the body goes here
HN  - 2012

MH  - Total Disc Replacement
UI  - D059145
MN  - E4.555.110.110.850
MN  - E4.650.110.850
MS  - The replacement of intervertebral discs in the spinal column with aritificial devices. The procedure is done in the lumbar or cervical spine to relieve severe pain resulting from INTERVERTEBRAL DISC DEGENERATION.
HN  - 2012

MH  - Toxicity Tests, Subacute
UI  - D059551
MN  - E5.940.850
MS  - Experiments designed to determine the potential toxic effects of a short-term (a few weeks) exposure to a chemical or chemicals.
AN  - ACUTE TOXICITY TESTS is also available
HN  - 2012

MH  - Toxicity Tests, Subchronic
UI  - D059550
MN  - E5.940.900
MS  - Experiments designed to determine the potential toxic effects of mid-term (a few months) exposure to a chemical or chemicals.
AN  - TOXICITY TESTS, CHRONIC is also available
HN  - 2012

MH  - Transcriptome
UI  - D059467
MN  - G2.111.87.847.750
MN  - G2.149.115.847.750
MN  - G5.355.310.700.750
MN  - G5.360.920
MS  - The pattern of GENE EXPRESSION, at the level of genetic transcription, in a specific organism or under specific circumstances in specific cells.
HN  - 2012; use GENE EXPRESSION PROFILING 2006-2011
BX  - Transcriptomes
FX  - Exome
FX  - Gene Expression Profiling

MH  - Transferrins
UI  - D061250
MN  - D12.776.157.427.750
MN  - D12.776.556.579.750
MS  - A group of iron-binding proteins that tightly bind two ferrate ions along with two carbonate ions. They are found in the bodily fluids of vertebrates where they act as transport and storage molecules for iron.
AN  - TRANSFERRIN is also available
HN  - 2012

MH  - Transient Tachypnea of the Newborn
UI  - D059245
MN  - C8.381.842.737
MN  - C8.618.842.737
MN  - C8.618.961.500
MN  - C16.614.521.563.737
MN  - C23.888.852.944.500
MS  - Abnormal increase in RESPIRATORY RATE in the newborn. It is self-limiting and attributed to the delayed fetal lung fluid clearance often in CAESAREAN SECTION delivery.
AN  - check the tag INFANT, NEWBORN
HN  - 2012

MH  - Transition to Adult Care
UI  - D060305
MN  - N2.421.912
MN  - N4.590.233.727.210.500
MS  - Transfer from pediatric to adult care.
HN  - 2012

MH  - Transplant Donor Site
UI  - D060053
MN  - A1.935
MS  - The body location or part from which tissue is taken for TRANSPLANTATION.
HN  - 2012
FX  - Tissue Donors

MH  - Trichosporonosis
UI  - D060586
MN  - C1.703.875
MN  - C8.381.483.125.841
MN  - C8.674.55.682
MN  - C20.543.480.680.75.682
MS  - Fungal infections caused by TRICHOSPORON that may become systemic especially in an IMMUNOCOMPROMISED HOST. Clinical manifestations range from superficial cutaneous infections to systemic lesions in multiple organs.
HN  - 2012

MH  - Trigeminal Nerve Injuries
UI  - D061221
MN  - C10.292.262.875
MN  - C10.292.775.349
MN  - C10.900.300.218.775
MN  - C26.260.237.825
MN  - C26.915.300.400.825
MS  - Traumatic injuries to the TRIGEMINAL NERVE. It may result in extreme pain, abnormal sensation in the areas the nerve innervates on face, jaw, gums and tongue and can cause difficulties with speech and chewing.  It is sometimes associated with various dental treatments.
HN  - 2012

MH  - Trigger Points
UI  - D061028
MN  - A1.947
MS  - Specific locations in the body which when stimulated will give rise to sensations or symptoms elsewhere in the body.
AN  - for trigger point injections, coordinate with INJECTIONS or specifics
HN  - 2012
FX  - Acupuncture Points

MH  - Trochlear Nerve Injuries
UI  - D061247
MN  - C10.292.262.906
MN  - C10.900.300.218.831
MN  - C26.260.237.868
MN  - C26.915.300.400.868
MS  - Traumatic injuries to the TROCHLEAR NERVE.
HN  - 2012

MH  - Ultrasonic Surgical Procedures
UI  - D059708
MN  - E4.943
MS  - The use of HIGH-ENERGY SHOCK WAVES, in the frequency range of 20-60 kHz, to cut through or remove tissue. The tissue fragmentation by ultrasonic surgical instruments is caused by mechanical effects not heat as with HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION.
HN  - 2012
FX  - Ultrasonic Therapy

MH  - Unrelated Donors
UI  - D061349
MN  - M1.898.828
MS  - Providers of tissues for transplant to non-related individuals.
HN  - 2012

MH  - Urine Specimen Collection
UI  - D059349
MN  - E1.370.225.998.762
MN  - E5.200.998.762
MS  - Methods or procedures used to obtain samples of URINE.
HN  - 2012

MH  - Uroplakin Ia
UI  - D060167
MN  - D12.776.395.550.942.100
MN  - D12.776.543.550.942.100
MN  - D12.776.543.982.750
MS  - A tetraspanin domain-containing uroplakin subtype. It heterodimerizes with UROPLAKIN II to form a component of the asymmetric unit membrane found in urothelial cells.
HN  - 2012

MH  - Uroplakin Ib
UI  - D060169
MN  - D12.776.395.550.942.150
MN  - D12.776.543.550.942.150
MN  - D12.776.543.982.875
MS  - A tetraspanin domain-containing uroplakin subtype. It heterodimerizes with UROPLAKIN III to form a component of the asymmetric unit membrane found in urothelial cells.
HN  - 2012

MH  - Uroplakin II
UI  - D060170
MN  - D12.776.395.550.942.200
MN  - D12.776.543.550.942.200
MS  - A uroplakin subtype that heterodimerizes with UROPLAKIN IA to form a component of the asymmetric unit membrane found in urothelial cells.
HN  - 2012(1994)

MH  - Uroplakin III
UI  - D060171
MN  - D12.776.395.550.942.300
MN  - D12.776.543.550.942.300
MS  - A uroplakin subtype that heterodimerizes with UROPLAKIN IB to form a component of the asymmetric unit membrane found in urothelial cells.
HN  - 2012(1994)

MH  - Uroplakins
UI  - D060165
MN  - D12.776.395.550.942
MN  - D12.776.543.550.942
MS  - Specialized membrane glycoproteins that are found on UROTHELIUM cells. They associate into a hexagonal array of 16-nm cell surface particles which form the asymmetric unit membrane of urothelial plaques.
AN  - general or unspecified; prefer specifics
HN  - 2012

MH  - Uterine Retroversion
UI  - D060725
MN  - C13.351.500.852.952
MN  - C23.300.970.750
MS  - A condition in which the UTERUS is found tilted backward toward the spine. The uterus is more commonly found in a straight vertical or anteverted (tipped forward) position. Although retroverted uterus is a normal variant position without symptoms, it is sometimes associated with pain, discomfort and other pregnancy complications.
AN  - coordinate with OBSTETRIC LABOR COMPLICATIONS if pertinent
HN  - 2012

MH  - V(D)J Recombination
UI  - D060152
MN  - G5.355.330.900
MN  - G5.355.760.932
MS  - The process by which the V (variable), D (diversity), and J (joining) segments of IMMUNOGLOBULIN GENES or T-CELL RECEPTOR GENES are assembled during the development of LYMPHOID CELLS using NONHOMOLOGOUS DNA END-JOINING.
HN  - 2012
FX  - VDJ Exons
FX  - VDJ Recombinases

MH  - V-Set Domain-Containing T-Cell Activation Inhibitor 1
UI  - D060907
MN  - D12.776.467.150.900
MN  - D12.776.543.95.900
MN  - D23.50.301.264.35.276.900
MN  - D23.50.301.285.900
MN  - D23.101.100.110.276.900
MN  - D23.529.168.900
MS  - A B7 antigen subtype that inhibits the costimulation of T-cell activation, proliferation, cytokine production and development of cytotoxicity. The over expression of this protein in a variety of tumor cell types suggests its role in TUMOR IMMUNE EVASION.
HN  - 2012

MH  - Vagus Nerve Injuries
UI  - D061223
MN  - C10.292.262.937
MN  - C10.292.887.399
MN  - C10.900.300.218.887
MN  - C26.260.237.912
MN  - C26.915.300.400.912
MS  - Traumatic injuries to the VAGUS NERVE. Because the vagus nerve innervates multiple organs, injuries in the nerve fibers may result in any gastrointestinal organ dysfunction downstream of the injury site.
HN  - 2012

MH  - Vascular Calcification
UI  - D061205
MN  - C18.452.174.130.780
MS  - Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels are associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.
HN  - 2012

MH  - Vascular Stiffness
UI  - D059289
MN  - G9.330.79
MS  - Loss of vascular ELASTICITY due to factors such as AGING; and ARTERIOSCLEROSIS. Increased arterial stiffness is one of the RISK FACTORS for many CARDIOVASCULAR DISEASES.
HN  - 2012
BX  - Arterial Stiffness
FX  - Vascular Calcification

MH  - Verrucomicrobia
UI  - D061327
MN  - B3.440.930
MN  - B3.950
MS  - A phylum of gram-negative bacteria containing seven class-level groups from a wide variety of environments. Most members are chemoheterotrophs.
HN  - 2012

MH  - Vestibulocochlear Nerve Injuries
UI  - D061285
MN  - C9.218.807.800.918
MN  - C10.292.262.968
MN  - C10.292.910.925
MN  - C10.900.300.218.943
MN  - C26.260.237.956
MN  - C26.915.300.400.956
MS  - Traumatic injuries to the VESTIBULOCOCHLEAR NERVE.
HN  - 2012

MH  - Visceral Pain
UI  - D059265
MN  - C10.597.617.735.500
MN  - C23.888.592.612.720.500
MN  - C23.888.646.511.500
MS  - Pain originating from internal organs (VISCERA) associated with autonomic phenomena (PALLOR; SWEATING; NAUSEA; and VOMITING). It often becomes a REFERRED PAIN.
HN  - 2012

MH  - Water Quality
UI  - D060753
MN  - N6.850.460.350.80.750
MN  - N6.850.460.790.730
MN  - N6.850.860.510.915.950
MS  - A rating of a body of water based on measurable physical, chemical, and biological characteristics.
HN  - 2012

MH  - Water Wells
UI  - D060986
MN  - G1.311.355.875
MN  - N6.850.860.510.915.975
MS  - Constructions built to access underground water.
HN  - 2012

MH  - Weight Reduction Programs
UI  - D061217
MN  - N2.370.650
MN  - N2.421.726.507.650
MS  - Services providing counseling and activities that help overweight individuals to attain a more healthy body weight.
HN  - 2012
FX  - Diet, Reducing

MH  - Wharton Jelly
UI  - D059631
MN  - A10.165.970
MS  - Jelly-like connective tissue of the UMBILICAL CORD that contains MESENCHYMAL STROMAL CELLS.
AN  - /cytol: consider also WHARTON JELLY CELLS see MESENCHYMAL STROMAL CELLS
HN  - 2012

MH  - White Coat Hypertension
UI  - D059466
MN  - C14.907.489.907
MS  - Phenomenon where BLOOD PRESSURE readings are elevated only when taken in clinical settings.
HN  - 2012
BX  - White Coat Syndrome

MH  - Wnt Signaling Pathway
UI  - D060449
MN  - G2.149.115.800.925
MS  - A complex signaling pathway whose name is derived from the DROSOPHILA Wg gene, which when mutated results in the wingless phenotype, and the vertebrate INT gene, which is located near integration sites of MOUSE MAMMARY TUMOR VIRUS. The signaling pathway is initiated by the binding of WNT PROTEINS to cells surface WNT RECEPTORS which interact with the AXIN SIGNALING COMPLEX and an array of second messengers that influence the actions of BETA CATENIN.
HN  - 2012

MH  - Wnt3 Protein
UI  - D060508
MN  - D12.776.467.984.300
MN  - D23.529.984.300
MS  - A Wnt protein subtype that plays a role in cell-cell signaling during EMBRYONIC DEVELOPMENT and the morphogenesis of the developing NEURAL TUBE. Defects in Wnt3 protein are associated with autosomal recessive tetra-AMELIA in humans.
HN  - 2012(1990)
BX  - Wnt3 Proteins

MH  - Wnt3A Protein
UI  - D060509
MN  - D12.776.467.984.350
MN  - D23.529.984.350
MS  - A Wnt protein subtype that plays a role in cell-cell signaling during EMBRYONIC DEVELOPMENT and the morphogenesis of the developing NEURAL TUBE.
HN  - 2012; use WNT3 PROTEIN 1990-2011

MH  - Wnt4 Protein
UI  - D060528
MN  - D12.776.467.984.400
MN  - D23.529.984.400
MS  - A Wnt protein that is involved in regulating multiple developmental processes such as the formation of the KIDNEY; ADRENAL GLANDS; MAMMARY GLANDS; the PITUITARY GLAND; and the female reproductive system. Defects in WNT4 are a cause of ROKITANSKY KUSTER HAUSER SYNDROME.
HN  - 2012(1994)
BX  - Wnt-4 Proteins

MH  - Zyxin
UI  - D060589
MN  - D12.776.220.995
MN  - D12.776.512.500
MN  - D12.776.744.962
MS  - A zinc-binding phosphoprotein that concentrates at focal adhesions and along the actin cytoskeleton. Zyxin has an N-terminal proline-rich domain and three LIM domains in its C-terminal half.
HN  - 2012
